Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Open accessAbstract
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) has revised its 2009 guidelines for the management of major depressive disorder (MDD) in adults by updating the evidence and recommendations. The target audiences for these 2016 guidelines are psychiatrists and other mental health professionals. Methods: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. "Psychological Treatments" is the second of six sections of the 2016 guidelines. Results: Evidence-informed responses were developed for 25 questions under 5 broad categories: 1) patient characteristics relevant to using psychological interventions; 2) therapist and health system characteristics associated with optimizing outcomes; 3) descriptions of major psychotherapies and their efficacy; 4) additional psychological interventions, such as peer interventions and computer- and technology-delivered interventions; and 5) combining and/or sequencing psychological and pharmacological interventions. Conclusions: First-line psychological treatment recommendations for acute MDD include cognitive-behavioural therapy (CBT), interpersonal therapy (IPT), and behavioural activation (BA). Second-line recommendations include computer-based and telephone-delivered psychotherapy. Where feasible, combining psychological treatment (CBT or IPT) with antidepressant treatment is recommended because combined treatment is superior to either treatment alone. First-line psychological treatments for maintenance include CBT and mindfulness-based cognitive therapy (MBCT). Patient preference, in combination with evidence-based treatments and clinician/system capacity, will yield the optimal treatment strategies for improving individual outcomes in MDD. © The Author(s) 2016.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
64 of 178 cited sources checked · 23 supported · 1 flagged · accuracy not yet measured
- Premisecitation
There is Level 2 Evidence for treatment of depression with co-occurring cardiovascular disease for CBT, interpersonal therapy (IPT), and problem-solving therapy (PST).
“there is Level 2 Evidence for treatment of depression with co-occurring cardiovascular disease for CBT, interpersonal therapy (IPT), and problem-solving therapy (PST).25,[27][28][29]”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [25] 25. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109. source
- cites [27] 27. Dickens C, Cherrington A, Adeyemi I, et al. Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and meta- regression. Psychosom Med. 2013;75:211-221. source
- cites [28] 28. Mavrides N, Nemeroff C. Treatment of depression in cardio- vascular disease. Depress Anxiety. 2013;30:328-341. source
The Psychotherapeutic Interventions section reports improved depression scores for a problem-solving-therapy intervention that could also include medication, and the Discussion reports a positive CBT trial. But the Discussion says psychotherapy trial results were mixed and IPT showed no additional benefit over usual care. The paper does not assign these therapies a “Level 2 Evidence” rating. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
The magnitude of benefit for psychological treatment appears to increase with increasing severity.
“the magnitude of benefit for psychological treatment appears to increase with increasing severity, 17”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [17] 17. Bower P, Kontopantelis E, Sutton A, et al. Influence of initial severity of depression on effectiveness of low intensity inter- ventions: meta-analysis of individual patient data. BMJ. 2013;346:f540. source
The section on whether baseline severity moderates effectiveness reports that more severely depressed patients had larger treatment effects. But the analysis concerns low-intensity interventions for depression, not psychological treatment generally; the increase was small and might not be clinically significant. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Psychological treatments are beneficial even for subthreshold depressive symptoms.
“there is evidence that psychological treatments are beneficial even for subthreshold depressive symptoms.18”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] 18. Cuijpers P, Koole SL, van Dijke A, et al. Psychotherapy for subclinical depression: meta-analysis. Br J Psychiatry. 2014; 205:268-274. source
- Premisecitation
In persistent depressive disorder (PDD), medication treatment or combination of medication with psychological treatment provides more benefit than psychological treatment alone.
“In persistent depressive disorder (PDD), medication treatment or combination of medication with psychological treatment provides more benefit than psychological treatment alone.12,13”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [12] 12. Cuijpers P, Huibers M, Ebert DD, et al. How much psy- chotherapy is needed to treat depression? A metaregression analysis. J Affect Disord. 2013;149:1-13. source
- cites [13] 13. Kriston L, von Wolff A, Westphal A, et al. Efficacy and acceptability of acute treatments for persistent depressive dis- order: a network meta-analysis. Depress Anxiety. 2014;31: 621-630. source
The Efficacy and Acceptability of Psychotherapeutic and Combined Treatments section (page not provided) reports that medication was more effective than interpersonal psychotherapy (IPT) alone, and that IPT plus medication was more effective than medication alone at borderline significance. But it found no significant efficacy difference between medication and CBASP, with or without medication. The claim overgeneralizes these treatment-specific findings to psychological treatment alone across PDD. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Psychological treatments in general and CBT in particular appear to be equally effective for different subtypes of depression, including atypical, melancholic, and anxious depression.
“Psychological treatments in general and cognitive-behavioural therapy (CBT) in particular appear to be equally effective for different subtypes of depression, including atypical depression, melancholic depression, and anxious depression.9,10”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [9] 9. Simon GE, Perlis RH. Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry. 2010;167:1445-1455. source
The Selection of a Specific Psychotherapy section discusses whether clinical characteristics predict different responses to cognitive therapy and other psychotherapies, but does not compare effectiveness across atypical, melancholic, and anxious depression. The section on specific antidepressants discusses atypical symptoms and anxiety only in relation to medication response. Searches for these subtypes alongside psychotherapy and CBT found no passage supporting the cited claim; page numbers were not available in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites [10] 10. Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psy- chiatr Clin North Am. 2010;33:537-555. source
In “CBT for severe depression” (page unavailable), the paper reports that cognitive therapy was as efficacious as phenelzine for atypical depression. In “Illness characteristics” (page unavailable), it says there is little evidence that melancholic depression responds less well to CBT than to medication. It does not establish equal effectiveness across the named subtypes, address anxious depression, or make that subtype-wide claim for psychological treatments generally. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
More women than men prefer psychological treatment over medication treatment.
“More women than men prefer psychological treatment over medication treatment.36”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [36] 36. McHugh RK, Whitton SW, Peckham AD, et al. Patient pre- ference for psychological vs pharmacologic treatment of psy- chiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013;74:595-602. source
- Premisecitation
Collecting patient feedback helps to track symptoms, experience of treatment, and functioning using validated scales such that changes can be made if patients are not improving.
“The collecting of patient feedback helps to track symptoms, experience of treatment, and functioning using validated scales (e.g., the Patient Health Questionnaire-9 [PHQ-9] 51 ) such that changes can be made if patients are not improving.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [51] 51. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16:606-613. source
- Premisecitation
Meta-analyses concluded that group psychological therapy for depression is more effective than treatment as usual.
“Meta-analyses that evaluated efficacy of group psychological therapy for depression concluded that it is more effective than treatment as usual.77,78”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [77] 77. Huntley AL, Araya R, Salisbury C. Group psychological therapies for depression in the community: systematic review and meta-analysis. Br J Psychiatry. 2012;200:184-190. source
- cites [78] 78. Okumura Y, Ichikura K. Efficacy and acceptability of group cognitive behavioral therapy for depression: a sys- tematic review and meta-analysis. J Affect Disord. 2014; 164:155-164. source
- Premisecitation
There is limited evidence of efficacy for long-term PDT for acute MDD treatment.
“there is limited evidence of efficacy for acute MDD treatment.74”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [74] 74. Fonagy P, Rost F, Carlyle J, et al. Pragmatic randomized con- trolled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry. 2015;14:312-321. source
The paper's introductory discussion (indexed under Abstract; page not supplied) says evidence-gathering on longer-term psychoanalytic treatments is in its early stages, supporting the claim that evidence is limited. But the trial studies treatment-resistant depression and does not establish that evidence is limited specifically for acute MDD treatment. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Findingcitation
A single additional face-to-face study together with a new meta-analysis including many older, small studies elevate behavioural activation (BA) to first-line treatment.
“a single additional faceto-face study together with a new meta-analysis including many older, small studies elevate behavioural activation (BA) to first-line treatment.70,71”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [70] 70. Carlbring P, Ha ¨gglund M, Luthstro ¨m A, et al. Internet-based behavioral activation and acceptance-based treatment for depression: a randomized controlled trial. J Affect Disord. 2013;148:331-337. source
- cites [71] 71. Moradveisi L, Huibers MJH, Renner F, et al. Behavioural acti- vation v. antidepressant medication for treating depression in Iran: randomised trial. Br J Psychiatry. 2013;202:204-211. source
- Premisecitation
Two meta-analyses looking at brief (8 or fewer sessions) CBT, MBCT, and PST noted significant efficacy in symptom reduction.
“while 2 other meta-analyses looking at brief (8 or fewer sessions) of CBT, MBCT, and PST noted significant efficacy in symptom reduction.82,83”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [82] 82. Cape J, Whittington C, Buszewicz M, et al. Psychological therapies for anxiety and depression in primary care: meta- analysis and meta-regression. BMC Med. 2010;8:38. source
The Abstract Results and Conclusions report that brief CBT and PST were effective for anxiety or depression in primary care. The Methods (Inclusion criteria; page unavailable) define brief therapy as more than two and fewer than 10 appointments, which can include nine—not strictly eight or fewer. This paper does not report on MBCT, so it does not support that part of the jointly cited claim. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [83] 83. Nieuwsma JA, Trivedi RB, McDuffie J, et al. Brief psy- chotherapy for depression: a systematic review and meta- analysis. Int J Psychiatry Med. 2012;43:129-151. source
The Results report a significant reduction in depressive symptoms in the meta-analysis of six to eight CBT sessions. The Results also report a positive finding for eight-session MBCT, but that finding came from a single study, not a meta-analysis. For PST, one reviewed analysis found a significant effect when PST and CBT were combined, while another found a statistically nonsignificant effect for PST alone. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
The combination of CBT and an antidepressant is more effective than either alone.
“the combination of CBT and an antidepressant is more effective than either alone.57,88,89”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [57] 57. Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013; 58:376-385. source
The Clinical Implications (p. 3) and Discussion (p. 10) say that CBT combined with pharmacotherapy is more effective than pharmacotherapy alone. They do not establish that the combination is more effective than CBT alone, so the claim’s “either alone” wording goes beyond this source. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [88] 88. Cuijpers P. Psychotherapies for adult depression: recent developments. Curr Opin Psychiatry. 2015;28:24-29. source
- cites [89] 89. Wiles NJ, Thomas L, Turner N, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depres- sion in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry. 2016;3:137-144. source
The Summary (p. 2) reports better long-term depression outcomes with CBT added to usual care, which included antidepressants, than with usual care alone. The trial did not compare the combination with CBT alone, and its participants were primary-care patients whose depression had not responded to antidepressants; it therefore does not establish the broader claim that the combination is better than either treatment alone. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
A number of trials have demonstrated the efficacy of an 8-session CBT intervention.
“A number of trials have demonstrated the efficacy of an 8-session CBT intervention.79,80”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [79] 79. Simon GE, Ludman EJ, Tutty S, et al. Telephone psychother- apy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004;292:935-942. source
- cites [80] 80. Lam RW, Parikh SV, Ramasubbu R, et al. Effects of com- bined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Br J Psychia- try. 2013;203:358-365. source
The CBT condition and Method sections describe an eight-session telephone CBT intervention, and the Work functioning outcomes section reports greater improvement than escitalopram alone on some productivity measures. But this paper reports one trial, not a number of trials, and its Clinical outcomes section found no significant additional benefit for depressive symptoms. It therefore supports a narrower efficacy claim than the citing sentence makes. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
A review of 4 small trials of an 8-session brief IPT intervention in depressed women found efficacy.
“A review of 4 small trials of an 8-session brief IPT intervention in depressed women also found efficacy, 81”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [81] 81. Swartz HA, Grote NK, Graham P. Brief interpersonal psy- chotherapy (IPT-B): overview and review of evidence. Am J Psychother. 2014;68:443-462. source
The Abstract describes IPT-B as an eight-session intervention and says the review finds evidence supporting it; the Introduction reports favorable outcomes in small studies of depressed women. But the Abstract says the review covers eight studies—four open studies, one matched case-control study, and three randomized trials—not four trials. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
There was no difference between the CBT group and those who continued pharmacotherapy at 1-year follow-up.
“There was no difference, however, between the CBT group and those who continued pharmacotherapy at 1-year follow-up.57”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [57] 57. Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013; 58:376-385. source
The “CBT, Compared With Pharmacotherapy” section (p. 8) reports no significant overall difference, but that finding concerns short-term outcomes. The Discussion (p. 10) says this meta-analysis did not examine long-term efficacy and reports lower relapse rates after one- and two-year follow-up for people who received CBT than for people treated with pharmacotherapy. It does not establish the claimed lack of difference at one year against continued pharmacotherapy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
A meta-analysis of 9 RCTs comparing CBT and pharmacotherapy concluded that after 1 year, those who received CBT in the acute phase of depressive illness had a lower rate of relapse than those who discontinued medication.
“a meta-analysis of 9 RCTs comparing CBT and pharmacotherapy concluded that after 1 year, those who received CBT in the acute phase of depressive illness had a lower rate of relapse than those who discontinued medication.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [57] 57. Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013; 58:376-385. source
The Discussion (p. 10) reports that another meta-analysis found lower relapse rates after one- and two-year follow-up among people who received CBT than among those treated with pharmacotherapy. But this paper says its own meta-analysis examined only short-term outcomes; it does not establish the claimed nine RCTs or specify a comparison with people who discontinued medication. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
A subsequent systematic review of comparative outcomes between IPT and other psychological treatments (8 studies, N=1233) concluded that differences were small.
“A subsequent systematic review of comparative outcomes between IPT and other psychological treatments (8 studies, N ¼ 1233) concluded that differences were small.66”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [66] 66. van Hees MLJM, Rotter T, Ellermann T, et al. The effective- ness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systema- tic review. BMC Psychiatry. 2013;13:22. source
The Conclusions state that differences between treatment effects were very small and often not significant. The review included eight studies and 1,233 patients, but its study descriptions show comparisons with pharmacotherapy, usual care and a wait-list condition as well as other psychological treatments. Thus, the claim describes the review’s comparisons too narrowly. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Evidence has accrued to suggest that MBCT may only be efficacious or advantageous over other forms of aftercare for those patients with greater vulnerability, in the form of recurrent depression, unstable remission, or a history of childhood trauma.
“evidence has accrued to suggest that MBCT may only be efficacious or advantageous over other forms of aftercare for those patients with greater vulnerability, in the form of recurrent depression, 97,98 unstable remission, 99,100 or a history of childhood trauma 98”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [97] 97. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72:31-40. source
- cites [98] 98. Teasdale JD, Segal ZV, Williams JM, et al. Prevention of relapse/recurrence in major depression by mindfulness- based cognitive therapy. J Consult Clin Psychol. 2000;68: 615-623. source
- cites [99] 99. Segal ZV, Bieling P, Young T, et al. Antidepressant monother- apy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recur- rent depression. Arch Gen Psychiatry. 2010;67:1256-1264. source
- Premisecitation
A subsequent meta-analysis (26 RCTs, N=1524) that incorporated older studies, the Internet/smartphone studies, and 1 recent face-to-face trial reported a large effect size of BA compared to control conditions.
“A subsequent meta-analysis (26 RCTs, N ¼ 1524) that incorporated older studies, the Internet/smartphone studies, and 1 recent face-to-face trial reported a large effect size of BA compared to control conditions.130,131”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [130] 130. Ekers D, Webster L, Van Straten A, et al. Behavioural activa- tion for depression: an update of meta-analysis of effective- ness and sub group analysis. PLoS One. 2014;96:e100100. source
The Introduction says this meta-analysis updated earlier reviews, and the Results report a large BA-versus-control effect (g = −0.74). The paper gives 26 RCTs and 1,524 participants for the review overall, but the control comparison used 25 studies and 1,088 participants. The Description of Studies identifies two web-based studies; the cited passages do not establish that smartphone studies or exactly one recent face-to-face trial were included. No page numbers are available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [131] 131. Moradveisi L1, Huibers MJ, Renner F, et al. Behavioural activation v. antidepressant medication for treating depres- sion in Iran: randomised trial. Br J Psychiatry. 2013;202: 204-211. source
- Interpretationreasoning
Level 2 Evidence supports CBASP as a second-line monotherapy, or in combination with antidepressants, for partial-responding or nonresponding patients, in the treatment of PDD.
“Overall, Level 2 Evidence supports CBASP as a second-line monotherapy, or in combination with antidepressants, for partial-responding or nonresponding patients, in the treatment of PDD.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [75] 75. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al. Cognitive behavioral analysis system of psychotherapy and brief sup- portive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009;66:1178-1188. source
The Conclusions section (page unavailable) reports earlier evidence that CBASP had an additive effect with an antidepressant and appeared effective as a switch option. But this trial did not test CBASP monotherapy, and its Results section (page unavailable) found no significant benefit from adding CBASP to medication for patients who had not fully responded. The paper does not assign a “Level 2” evidence rating. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [115] 115. Schatzberg AF, Rush AJ, Arnow BA, et al. Chronic depres- sion: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005; 62:513-520. source
- cites [116] 116. Schramm E, Zobel I, Dykierek P, et al. Cognitive behavioral analysis system of psychotherapy versus interpersonal psy- chotherapy for early-onset chronic depression: a randomized pilot study. J Affect Disord. 2011;129:109-116. source
- Findingcitation
Subsequent clinical trials evaluating BA in MDD have almost exclusively involved Internet- or smartphone-delivered treatments as opposed to in-person therapy.
“Subsequent clinical trials evaluating BA in MDD have almost exclusively involved Internet-or smartphone-delivered treatments as opposed to in-person therapy.70,128,129”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [70] 70. Carlbring P, Ha ¨gglund M, Luthstro ¨m A, et al. Internet-based behavioral activation and acceptance-based treatment for depression: a randomized controlled trial. J Affect Disord. 2013;148:331-337. source
- cites [128] 128. Moritz S, Kelly MT, Xu TJ, et al. A spirituality teaching program for depression: qualitative findings on cognitive and emotional change. Complement Ther Med. 2011;19:201-207. source
- cites [129] 129. Ly KH, Janni E, Wrede R, et al. Experiences of a guided smartphone-based behavioral activation therapy for depres- sion: a qualitative study. Internet Interv. 2015;2:60-68. source
The Background describes a randomized trial of smartphone-delivered behavioral activation, and the References list an Internet-based behavioral activation trial. But this qualitative study does not establish that subsequent BA trials in MDD were almost exclusively digital rather than in-person. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Meta-analyses and reviews of computer-based psychological treatment for MDD, whether delivered over the Internet or as a stand-alone program, confirm efficacy.
“Meta-analyses and reviews of computer-based psychological treatment for the treatment of MDD, whether delivered over the Internet or as a stand-alone program, confirm efficacy.[144][145][146][147][148][149][150]”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [144] 144. Andrews G, Cuijpers P, Craske MG, et al. Computer therapy for the anxiety and depressive disorders is effective, accep- table and practical health care: a meta-analysis. PLoS One. 2010;5:e13196. source
- cites [145] 145. Arnberg FK, Linton SJ, Hultcrantz M, et al. Internet-delivered psychological treatments for mood and anxiety disorders: a systematic review of their efficacy, safety, and cost-effective- ness. PLoS One. 2014;9:e98118. source
The ‘Mood disorders in adults’ section reports a large pooled effect for internet-delivered CBT versus waiting list in adults with depression, supporting efficacy for that treatment. The review’s eligibility criteria cover internet-delivered interventions, not stand-alone programs delivered without the internet; its conclusion also limits the supported use chiefly to CBT for adults with mild to moderate depression. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [146] 146. Vallury KD, Jones M, Oosterbroek C. Computerized cogni- tive behavior therapy for anxiety and depression in rural areas: a systematic review. J Med Internet Res. 2015;17:e139. source
The Discussion (Overview; page not given) says computerized CBT can be clinically effective for treating depression, and the Results (Efficacy; page not given) report improvements in depression in a rural-participant study. The review does not specifically establish efficacy for MDD across both Internet-delivered and stand-alone programs; its conclusion also calls for further work to confirm the results. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationcitation
ACT may also have particular value in the presence of comorbid medical conditions.
“ACT may also have particular value in the presence of comorbid medical conditions.122”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [122] 122. A-Tjak JGL, Davis ML, Morina N, et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clini- cally relevant mental and physical health problems. Psy- chother Psychosom. 2015;84:30-36. source
The 'Effect Size as a Function of Target Problem' section reports that ACT outperformed controls for somatic complaints, supporting its potential value for physical health problems. The paper does not establish particular value when a medical condition is comorbid with another condition; its Discussion also says ACT was not more effective than established treatments. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Since 2009, there have been 3 meta-analyses with a comparison of ACT to CBT.
“Since 2009, there have been 3 meta-analyses with a comparison of ACT to CBT. [120][121][122]”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [120] 120. Powers MB, Zum Vorde Sive Vording MB, Emmelkamp PMG. Acceptance and commitment therapy: a meta- analytic review. Psychother Psychosom. 2009;78:73-80. source
- cites [121] 121. Ruiz FJ. Acceptance and commitment therapy versus tradi- tional cognitive behavioral therapy: a systematic review and meta-analysis of current empirical evidence. Int J Psychol Psychol Ther. 2012;12:333-357.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [122] 122. A-Tjak JGL, Davis ML, Morina N, et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clini- cally relevant mental and physical health problems. Psy- chother Psychosom. 2015;84:30-36. source
- Premisecitation
The same 8-session CBT phone intervention added to an antidepressant improved work performance and satisfaction compared to antidepressant alone.
“The same 8-session CBT phone intervention added to an antidepressant improved work performance and satisfaction compared to antidepressant alone.80”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [80] 80. Lam RW, Parikh SV, Ramasubbu R, et al. Effects of com- bined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Br J Psychia- try. 2013;203:358-365. source
The Method and CBT condition describe eight telephone CBT sessions added to escitalopram. Work functioning outcomes report greater improvement in self-rated performance for the CBT group than for the escitalopram-alone group. The Acceptability of telephone CBT section reports satisfaction with the therapy only among CBT participants; it does not show that satisfaction improved compared with the control group. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Interpretationcitation
Level 2 Evidence supports MBCT as a second-line alternative to long-term maintenance antidepressant treatment.
“MBCT is recommended as a secondline alternative to long-term maintenance antidepressant treatment (Level 2 Evidence).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [69] 69. Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost- effectiveness of mindfulness-based cognitive therapy com- pared with maintenance antidepressant treatment in the pre- vention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386:63-73. source
The Additional information section says the trial supports MBCT with tapering support as an alternative to maintenance antidepressants for preventing relapse or recurrence. The Discussion likewise says it might offer protection for patients who want an alternative. Our copy does not designate MBCT a second-line treatment or assign a Level 2 evidence grade; page numbers were not supplied. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
There is limited evidence of efficacy of videoconferenced psychological treatment for depression in several small RCTs.
“there is limited evidence of efficacy in several small RCTs, [156][157][158]”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [156] 156. Chakrabarti S. Usefulness of telepsychiatry: a critical evalua- tion of videoconferencing-based approaches. World J Psy- chiatry. 2015;5:286-304. source
- cites [157] 157. Khatri N, Marziali E, Tchernikov I, et al. Comparing telehealth-based and clinic-based group cognitive behavioral therapy for adults with depression and anxiety: a pilot study. Clin Interv Aging. 2014;9:765-770. source
The Discussion reports promising but preliminary results from a small study of videoconferenced group CBT, including improvement in depression severity for some participants. It also says participants chose their treatment format and calls for future randomization, so this paper does not support describing its study as an RCT. (LLM, conf=0.89)
Experimental — accuracy not yet measured - cites [158] 158. Stubbings DR, Rees CS, Roberts LD, et al. Comparing in- person to videoconference-based cognitive behavioral ther- apy for mood and anxiety disorders: randomized controlled trial. J Med Internet Res. 2013;15:e258. source
- Premisecitation
PDT (up to 60 sessions over 18 months) did not significantly increase the likelihood of remission.
“In contrast, PDT (up to 60 sessions over 18 months) did not significantly increase the likelihood of remission.74”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [74] 74. Fonagy P, Rost F, Carlyle J, et al. Pragmatic randomized con- trolled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry. 2015;14:312-321. source
The Treatments section describes 60 sessions over 18 months, and the Outcomes section reports no significant increase in complete remission at the end of treatment or at 42 months. But the unqualified claim overlooks significant increases in partial remission during follow-up and in remission of the major-depression diagnosis at 18 months (Outcomes; Table 2). Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Across psychiatric disorders, one meta-analysis found that guided Internet CBT was no different in outcomes from face-to-face CBT.
“Across psychiatric disorders, 1 meta-analysis 153 found that guided Internet CBT was no different in outcomes from face-to-face CBT”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [153] 153. Andersson G, Cuijpers P, Carlbring P, et al. Guided internet- based vs. face-to-face cognitive behavior therapy for psychia- tric and somatic disorders: a systematic review and meta- analysis. World Psychiatry. 2014;13:288-295. source
- Premisecitation
In a trial comparing updated versions of CBT and IPT with the established MoodGym online version of CBT with over 600 participants in each of 3 groups, self-guided IPT was similar to the other treatments in reducing depressive symptoms.
“1 trial compared updated versions of CBT and IPT with the established ''MoodGym'' online version of CBT with over 600 participants in each of the 3 groups; self-guided IPT was similar to the other treatments in reducing depressive symptoms.152”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [152] 152. Donker T, Bennett K, Bennett A, et al. Internet-delivered interpersonal psychotherapy versus internet-delivered cogni- tive behavioral therapy for adults with depressive symptoms: randomized controlled noninferiority trial. J Med Internet Res. 2013;15:e82. source
- Findingcitation
MBCT has emerged as a first-line maintenance treatment adjunctive to medication.
“MBCT has emerged as a first-line maintenance treatment adjunctive to medication.”
Quote in the paperSubstantial claim - Findingcitation
MBCT has new evidence to qualify as a second-line acute treatment.
“Mindfulnessbased cognitive therapy (MBCT) has new evidence to qualify as a second-line acute treatment.”
Quote in the paperSubstantial claim - Findingcitation
ACT remains a third-line treatment.
“therefore, ACT remains a third-line treatment.”
Quote in the paperSubstantial claim - Findingnone given
The evidence status for other types of psychotherapies has not changed significantly since the 2009 guidelines.
“The evidence status for other types of psychotherapies has not changed significantly since the 2009 guidelines.”
Quote in the paperNot a substantial claim - Findingreasoning
STPP has Level 2 Evidence.
“Consequently, STPP is recommended as a second-line therapy with Level 2 Evidence.”
Quote in the paperSubstantial claim - Findingreasoning
CBASP remains a second-line treatment for chronic depression.
“Therefore, CBASP remains a second-line treatment for chronic depression.”
Quote in the paperSubstantial claim - Findingreasoning
The limited evidence base confines general PDT-as separate from specific STPP-as a third-line treatment.
“Thus, the limited evidence base confines general PDT-as separate from specific STPP-as a third-line treatment.”
Quote in the paperSubstantial claim - Findingreasoning
There is Level 1 Evidence that brief interventions can be effective.
“Overall, there is Level 1 Evidence that brief interventions can be effective.”
Quote in the paperSubstantial claim - Findingcitation
There is Level 3 Evidence for more frequent treatment sessions, particularly at the start of therapy.
“Thus, more frequent treatment sessions, particularly at the start of therapy, should be considered (Level 3 Evidence).”
Quote in the paperSubstantial claim - Findingreasoning
Insufficient evidence exists to state a minimum dose of psychological treatment.
“In the absence of definitive ''dose-finding'' trials, insufficient evidence exists to state a minimum dose”
Quote in the paperSubstantial claim - Findingreasoning
CBT has Level 1 Evidence of efficacy for acute treatment of MDD.
“In summary, CBT has Level 1 Evidence of efficacy and continues to be recommended as a first-line treatment for acute treatment of MDD.”
Quote in the paperSubstantial claim - Findingreasoning
MBCT has Level 2 Evidence as an adjunctive treatment for acute depression.
“In summary, MBCT is recommended as a secondline adjunctive treatment (Level 2 Evidence) for acute depression”
Quote in the paperSubstantial claim - Findingreasoning
Level 1 Evidence supports IPT as a first-line treatment for acute depression.
“In summary, Level 1 Evidence supports IPT as a first-line treatment for acute depression.”
Quote in the paperSubstantial claim - Findingreasoning
CBT has Level 1 Evidence for maintenance therapy in MDD.
“In summary, CBT has Level 1 Evidence and is recommended as a first-line maintenance therapy, whether the CBT is delivered either in the acute or maintenance phase of MDD.”
Quote in the paperSubstantial claim - Findingreasoning
MBCT has Level 1 Evidence as a maintenance treatment.
“and as a first-line maintenance treatment (Level 1 Evidence).”
Quote in the paperSubstantial claim - Findingnone given
There are no trials of MI as a stand-alone treatment for MDD.
“There are no trials of MI as a stand-alone treatment for MDD”
Quote in the paperSubstantial claim - Findingnone given
Most studies of PST include a focus on depressive symptoms rather than formal MDD.
“since most studies include a focus on depressive symptoms rather than formal MDD”
Quote in the paperSubstantial claim - Findingcitation
Bibliotherapy has been tested in many older trials, particularly as RCTs involving a waitlist control compared to use of the book Feeling Good by David Burns.
“Bibliotherapy, the reading and use of self-help materials such as books to treat depression, has been tested in many older trials, particularly as RCTs involving a waitlist control compared to use of the book Feeling Good by David Burns.141”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [141] 141. Parikh SV, Segal ZV, Grigoriadis S, et al. Canadian Net- work for Mood and Anxiety Treatments (CANMAT) clin- ical guidelines for the management of major depressive disorder in adults: II. Psychotherapy alone or in combina- tion with antidepressant medication. J Affect Disord. 2009; 117(Suppl 1):S15-S25. source
- Findingnone given
Telephone-delivered psychological treatment remains the most studied model.
“Telephone-delivered psychological treatment remains the most studied model.”
Quote in the paperNot a substantial claim - Findingnone given
Relatively few studies have been done using videoconferencing for MDD.
“Relatively few studies have been done using videoconferencing for MDD”
Quote in the paperSubstantial claim - Findingcitation
The evidence for combined psychological treatment with antidepressants is primarily based on studies where individual CBT or IPT was combined with SSRIs or TCAs.
“The evidence is primarily based on studies where individual CBT or IPT was combined with SSRIs or TCAs.”
Quote in the paperNot a substantial claim - Findingnone given
A significant number of studies have evaluated other methods of telephone-delivered support and disease management in addition to CBT.
“In addition to CBT, a significant number of studies have evaluated other methods of telephone-delivered support and disease management.”
Quote in the paperNot a substantial claim - Findingnone given
The evidence for combined psychological and antidepressant treatment is mostly based on studies where either CBT or IPT was delivered alone and combined with SSRIs or TCAs.
“The evidence is mostly based on studies where either CBT or IPT was delivered alone and combined with selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs).”
Quote in the paperNot a substantial claim - Findingcitation
The effect size of the differences between combined treatment and psychological treatment alone or placebo is small to moderate.
“The small to moderate effect size of the differences”
Quote in the paperSubstantial claim - Findingcitation
The effect size of the difference between combined treatment and antidepressants alone was moderate.
“The effect size of the difference was moderate”
Quote in the paperSubstantial claim - Premisecitation
Severity of depression does not differentially predict outcomes of treatment with antidepressants and CBT.
“A subsequent meta-analysis confirmed that severity of depression does not differentially predict outcomes of treatment with antidepressants and CBT. 16”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] 16. Weitz ES, Hollon SD, Twisk J, et al. Baseline depression severity as moderator of depression outcomes between cog- nitive behavioral therapy vs pharmacotherapy: an individual patient data meta-analysis. JAMA Psychiatry. 2015;72: 1102-1109. source
- Premisecitation
CBT may be more effective than other treatments for depression with comorbid anxiety symptoms or disorders.
“but CBT may be more effective than other treatments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] 21. Schaffer A, McIntosh D, Goldstein BI, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012;24:6-22. source
- Premisecitation
The time course of improvement is typically faster with pharmacological than psychological treatment.
“since the time course of improvement is typically faster with pharmacological than psychological treatment, 19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] 19. Thase ME, Friedman ES, Biggs MM, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007;164:739-752. source
- Premisecitation
Level 2 Evidence supports a negative prognostic impact of comorbid personality disorder on treatment outcomes, including psychological treatments, in depression.
“Level 2 Evidence supports a negative prognostic impact of comorbid personality disorder on treatment outcomes, including psychological treatments, in depression (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] 20. McIntyre RS, Alsuwaidan M, Goldstein BI, et al. The Cana- dian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012;24:69-81. source
- Premisecitation
Level 2 Evidence exists for a variety of psychological treatments in cancer patients.
“Level 2 Evidence also exists for a variety of psychological treatments in cancer patients”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [25] 25. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109. source
- cites [30] 30. Piet J, Wu ¨rtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a sys- tematic review and meta-analysis. J Consult Clin Psychol. 2012;80:1007-1020. source
- Premisecitation
For epilepsy and migraines, there is Level 3 Evidence of efficacy of psychological treatments for comorbid depression or depressive symptoms.
“and Level 3 Evidence for epilepsy and migraines.25,33,34”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [25] 25. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109. source
- cites [33] 33. Mehndiratta P, Sajatovic M. Treatments for patients with comorbid epilepsy and depression: a systematic literature review. Epilepsy Behav. 2013;28:36-40. source
- cites [34] 34. Fernie BA, Kollmann J, Brown RG. Cognitive beha- vioural interventions for depression in chronic neurolo- gical conditions: a systematic review. J Psychosom Res. 2015;78:411-419. source
- Premisecitation
For multiple sclerosis and Parkinson's disease, there is Level 2 Evidence of efficacy of psychological treatments (almost always CBT) for comorbid depression or depressive symptoms.
“with Level 2 Evidence of efficacy for multiple sclerosis and Parkinson's disease”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [25] 25. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109. source
- cites [33] 33. Mehndiratta P, Sajatovic M. Treatments for patients with comorbid epilepsy and depression: a systematic literature review. Epilepsy Behav. 2013;28:36-40. source
- cites [34] 34. Fernie BA, Kollmann J, Brown RG. Cognitive beha- vioural interventions for depression in chronic neurolo- gical conditions: a systematic review. J Psychosom Res. 2015;78:411-419. source
- Premisecitation
In the presence of HIV, Level 1 Evidence supports a variety of psychological treatments, particularly CBT.
“In the presence of human immunodeficiency virus (HIV), Level 1 Evidence supports a variety of psychological treatments, particularly CBT 31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] 31. Sherr L, Clucas C, Harding R, et al. HIV and depression-a systematic review of interventions. Psychol Health Med. 2011;16:493-527. source
- Premisecitation
Level 2 Evidence supports integrated psychosocial treatment of alcohol misuse and depression.
“Level 2 Evidence supports integrated psychosocial treatment of alcohol misuse and depression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] 23. Beaulieu S, Saury S, Sareen J, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012;24:38-55. source
- Premisecitation
Insufficient evidence is available to support a positive or negative effect of anxiety symptoms or disorders on depression outcomes.
“Insufficient evidence is available to support a positive or negative effect of anxiety symptoms or disorders on depression outcomes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] 21. Schaffer A, McIntosh D, Goldstein BI, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012;24:6-22. source
- Premisecitation
CBT is effective for depressive symptoms in substance use disorders.
“CBT is also effective for depressive symptoms in substance use disorders”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] 23. Beaulieu S, Saury S, Sareen J, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012;24:38-55. source
- Premisecitation
Therapist supervision and feedback can improve patient outcomes.
“therapist supervision and feedback can improve patient outcomes, 52,53”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [52] 52. Shimokawa K, Lambert MJ, Smart DW. Enhancing treatment outcome of patients at risk of treatment failure: meta-analytic and mega-analytic review of a psychotherapy quality assur- ance system. J Consult Clin Psychol. 2010;78:298-311. source
- cites [53] 53. Simon W, Lambert MJ, Harris MW, et al. Providing patient progress information and clinical support tools to therapists: effects on patients at risk of treatment failure. Psychother Res. 2012;22:638-647. source
- Premisecitation
Therapist characteristics that promote a therapeutic alliance include being genuinely respectful and interested in the well-being and safety of the patient, with empathy for subjective experience.
“Therapist characteristics that promote a therapeutic alliance include being genuinely respectful and interested in the well-being and safety of the patient, with empathy for subjective experience.50”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] 50. Leszcz M, Pain C, Hunter J, et al. Psychotherapy essentials to go: achieving psychotherapy effectiveness. New York (NY): Norton; 2015.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Level 1 Evidence supports psychological treatment as first-line for perinatal women with mild to moderate depressive illness.
“with Level 1 Evidence to support psychological treatment as first-line for perinatal women with mild to moderate depressive illness.[37][38][39][40]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [37] 37. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obste- tricians and Gynecologists. Gen Hosp Psychiatry. 2009;31: 403-413. source
- cites [38] 38. Howard LM, Megnin-Viggars O, Symington I, et al. Antena- tal and postnatal mental health: summary of updated NICE guidance. BMJ. 2014;349:g7394. source
- cites [39] 39. Miniati M, Callari A, Calugi S, et al. Interpersonal psy- chotherapy for postpartum depression: a systematic review. Arch Womens Ment Health. 2014;17:257-268. source
- Premisecitation
For hepatitis C, only Level 3 Evidence exists for psychological treatments.
“for the strikingly high rates of depression accompanying hepatitis C, only Level 3 Evidence exists for psychological treatments”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25] 25. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109. source
- cites [35] 35. Neri S, Bertino G, Petralia A, et al. A multidisciplinary ther- apeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegy- lated interferon a and ribavirin. J Clin Gastroenterol. 2010;44: e210-e217. source
- Premisecitation
There is substantial evidence of efficacy of CBT for MDD or PDD even in severely affected individuals and in those who had not responded to treatment with antidepressants.
“With more than 40 original reports and meta-analyses published on CBT for MDD or PDD since 2009, there is substantial evidence of efficacy even in severely affected individuals and in those who had not responded to treatment with antidepressants.62,63”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [62] 62. Hollon SD, DeRubeis RJ, Fawcett J, et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71: 1157-1164. source
- cites [63] 63. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381: 375-384. source
- Premisecitation
An updated meta-analysis of acceptance and commitment therapy (ACT) concluded that there is insufficient evidence of efficacy.
“An updated meta-analysis of acceptance and commitment therapy (ACT) concluded that there is insufficient evidence of efficacy 76”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [76] 76. Ost L-G. The efficacy of acceptance and commitment ther- apy: an updated systematic review and meta-analysis. Behav Res Ther. 2014;61:105-121. source
- Premisecitation
Short-term psychodynamic psychotherapy (STPP) compared to other types of psychotherapies resulted in slightly worse outcomes on some measures of depression at the end of treatment.
“Short-term psychodynamic psychotherapy (STPP) compared to other types of psychotherapies resulted in slightly worse outcomes on some measures of depression at the end of treatment.61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
When both CBT and pharmacotherapy are of high quality, the addition of CBT to pharmacotherapy increases recovery rates.
“Results of a recent RCT 62 suggested that when both CBT and pharmacotherapy are of high quality, the addition of CBT to pharmacotherapy increases recovery rates.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] 62. Hollon SD, DeRubeis RJ, Fawcett J, et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71: 1157-1164. source
- Premisecitation
CBT is as effective as antidepressant medication.
“The authors found that CBT is as effective as antidepressant medication, 88”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] 88. Cuijpers P. Psychotherapies for adult depression: recent developments. Curr Opin Psychiatry. 2015;28:24-29. source
- Premisecitation
CBT is effective for people with treatment-resistant depression (i.e., those who did not respond to at least 2 adequate antidepressant trials).
“CBT is also effective for people with treatment-resistant depression (i.e., those who did not respond to at least 2 adequate antidepressant trials).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] 63. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381: 375-384. source
- Interpretationcitation
During maintenance phase treatment, CBT and pharmacotherapy provide comparable prevention of relapse.
“During maintenance phase treatment, CBT and pharmacotherapy provide comparable prevention of relapse.”
Quote in the paperSubstantial claim - Premisecitation
The comparison of CBT delivered during remission with pharmacotherapy did not show a significant difference in relapse.
“The comparison with pharmacotherapy did not show a significant difference.91”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] 91. Biesheuvel-Leliefeld KEM, Kok GD, Bockting CLH, et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta- regression. J Affect Disord. 2015;174:400-410. source
- Premisecitation
The effect of adding CBT to pharmacotherapy on recovery rates is limited to participants with severe nonchronic depression.
“When participant characteristics were taken into account, this effect was limited to participants with severe nonchronic depression.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] 62. Hollon SD, DeRubeis RJ, Fawcett J, et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71: 1157-1164. source
- Premisecitation
In a recent analysis of 70 controlled studies (N=5403), there was a strong positive association between increased frequency of psychological treatment sessions per week and increased size of clinical improvement.
“however, a strong positive association was found for increased frequency of psychological treatment sessions per week and increased size of clinical improvement.12”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] 12. Cuijpers P, Huibers M, Ebert DD, et al. How much psy- chotherapy is needed to treat depression? A metaregression analysis. J Affect Disord. 2013;149:1-13. source
- Premisecitation
In a subsequent meta-analysis, CBT delivered during remission decreased the likelihood of relapse by 32%.
“In a subsequent meta-analysis, which included more heterogeneous studies, CBT delivered during remission decreased the likelihood of relapse by 32%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] 91. Biesheuvel-Leliefeld KEM, Kok GD, Bockting CLH, et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta- regression. J Affect Disord. 2015;174:400-410. source
- Interpretationcitation
To prevent depressive relapse/recurrence, CBT versus pharmacotherapy delivered during the acute phase offers better protection.
“To prevent depressive relapse/recurrence, CBT versus pharmacotherapy delivered during the acute phase offers better protection.”
Quote in the paperSubstantial claim - Premisecitation
In a recent analysis of 70 controlled studies (N=5403), which account for natural recovery, there was no association between clinical improvement and the number of psychological treatment sessions or hours.
“in a recent analysis of 70 controlled studies (N ¼ 5403), which account for natural recovery, there was no association between clinical improvement and the number of psychological treatment sessions or hours”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] 12. Cuijpers P, Huibers M, Ebert DD, et al. How much psy- chotherapy is needed to treat depression? A metaregression analysis. J Affect Disord. 2013;149:1-13. source
- Premisecitation
Combined IPT with pharmacotherapy is more effective than pharmacotherapy alone for maintenance treatment of depression.
“a meta-analysis demonstrates that combined IPT with pharmacotherapy treatment was more effective than pharmacotherapy alone.65”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] 65. Cuijpers P, Geraedts AS, van Oppen P, et al. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychia- try. 2011;168:581-592. source
- Premisecitation
MBCT improves clinical outcomes via changes in mindfulness, rumination, worry, compassion, and metaawareness, consistent with underlying theory.
“MBCT improves clinical outcomes via changes in mindfulness, rumination, worry, compassion, and metaawareness, consistent with underlying theory.93”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] 93. van der Velden AM, Kuyken W, Wattar U, et al. A systematic review of mechanisms of change in mindfulness-based cog- nitive therapy in the treatment of recurrent major depressive disorder. Clin Psychol Rev. 2015;37:26-39. source
- Premisecitation
MBCT has exhibited comparable efficacy to group CBT.
“and comparable efficacy to group CBT, 105”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] 105. Manicavasgar V, Parker G, Perich T. Mindfulness-based cog- nitive therapy vs cognitive behaviour therapy as a treatment for non-melancholic depression. J Affect Disord. 2011;130: 138-144. source
- Interpretationreasoning
Heterogeneity among treatment formats (individualized vs. group) and small sample size in the studies reduce evidence for combined IPT with pharmacotherapy as maintenance treatment to Level 2.
“However, heterogeneity among the treatment formats (individualized vs. group) and small sample size in the studies reduce evidence to Level 2”
Quote in the paperSubstantial claim - Interpretationcitation
In the treatment of the depressed patient with comorbid personality disorder, PDT may have particular utility.
“Similarly, in the treatment of the depressed patient with comorbid personality disorder, PDT may have particular utility.24”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] 24. Rosenbluth M, MacQueen G, McIntyre RS, et al. The Cana- dian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry. 2012;24:56-68. source
- Interpretationreasoning
In the absence of specific MDD studies, evidence for MI remains at Level 4 (expert opinion).
“In the absence of specific MDD studies, evidence remains at Level 4 (expert opinion)”
Quote in the paperSubstantial claim - Premisecitation
Other findings noted STPP was significantly less effective on depressive symptoms than alternative psychotherapies at posttreatment.
“while other findings noted STPP was significantly less effective on depressive symptoms than alternative psychotherapies at posttreatment.61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
Some analyses indicated STPP was similar to other psychotherapies in outcomes.
“but some analyses indicated STPP was similar to other psychotherapies in outcomes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
STPP was significantly more effective than waitlist or treatment-as-usual control conditions.
“STPP was significantly more effective than waitlist or treatment-as-usual control conditions”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
MBCT has exhibited superior efficacy to a psychoeducation control treatment.
“MBCT has also exhibited superior efficacy to a psychoeducation control treatment 104”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] 104. Chiesa A, Castagner V, Andrisano C, et al. Mindfulness- based cognitive therapy vs. psycho-education for patients with major depression who did not achieve remission follow- ing antidepressant treatment. Psychiatry Res. 2015;226: 474-483. source
- Premisecitation
A meta-analysis (16 RCTs, N=1472) compared IPT to a control group for depression or depressive symptoms, with an effect size of 0.63.
“A meta-analysis (16 RCTs, N ¼ 1472) compared IPT to a control group for depression or depressive symptoms, with an effect size of 0.63.65”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] 65. Cuijpers P, Geraedts AS, van Oppen P, et al. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychia- try. 2011;168:581-592. source
- Premisecitation
Specific examination of IPT versus CBT for adults with MDD (7 trials, N=741) found no differences between them.
“Finally, specific examination of IPT versus CBT for adults with MDD (7 trials, N ¼ 741) found no differences between them.64”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] 64. Jakobsen JC, Hansen JL, Simonsen S, et al. Effects of cogni- tive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of rando- mized clinical trials with meta-analyses and trial sequential analyses. Psychol Med. 2012;42:1343-1357. source
- Interpretationreasoning
An absence of replication of specific models leaves evidence of efficacy for STPP at Level 2.
“but an absence of replication of specific models leaves evidence of efficacy at Level 2”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
A meta-analysis identified 54 studies (33 RCTs) of STPP.
“For STPP, a meta-analysis identified 54 studies (33 RCTs).61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Interpretationcitation
The literature shows increasing evidence of a variety of improvements in outcomes related to STPP.
“Overall, the literature shows increasing evidence of a variety of improvements in outcomes related to STPP”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
- Premisecitation
MBCT has exhibited efficacy as an augmentation to treatment as usual in a heterogeneous sample of both currently and remitted depressed outpatients, albeit with modest effect sizes.
“MBCT has exhibited efficacy as an augmentation to treatment as usual in a heterogeneous sample of both currently and remitted depressed outpatients, albeit with modest effect sizes.102,103”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [102] 102. van Aalderen JR, Donders ART, Giommi F, et al. The effi- cacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive epi- sode: a randomized controlled trial. Psychol Med. 2012;42: 989-1001. source
- cites [103] 103. van Aalderen JR, Donders ART, Peffer K, et al. Long-term outcome of mindfulness-based cognitive therapy in recurrently depressed patients with and without a depressive episode at baseline. Depress Anxiety. 2015;32:563-569. source
- Premisecitation
An RCT evaluating usual care versus prescription for Feeling Good found no difference in patient outcomes.
“an RCT evaluating usual care versus prescription for Feeling Good found no difference in patient outcomes.143”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [143] 143. Naylor EV, Antonuccio DO, Litt M, et al. Bibliotherapy as a treatment for depression in primary care. J Clin Psychol Med Settings. 2010;17:258-271. source
- Premisecitation
One RCT highlighted the need for physician guidance to ensure active engagement.
“Although 1 RCT 142 highlighted the need for physician guidance to ensure active engagement”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] 142. Joling KJ, van Hout HPJ, van't Veer-Tazelaar PJ, et al. How effective is bibliotherapy for very old adults with subthres- hold depression? A randomized controlled trial. Am J Geriatr Psychiatry. 2011;19:256-265. source
- Interpretationreasoning
In the absence of specific large trials in MDD, evidence for ACT remains at Level 3.
“In the absence of specific large trials in MDD, evidence remains at Level 3”
Quote in the paperSubstantial claim - Interpretationreasoning
There is insufficient evidence to recommend PST as a maintenance treatment.
“there is insufficient evidence to recommend PST as a maintenance treatment.”
Quote in the paperSubstantial claim - Premisecitation
PST has been shown to be more effective when training includes both positive problem orientation and problem-solving skills.
“It has been shown to be more effective when training includes both positive problem orientation and problem-solving skills.138”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [138] 138. Bell AC, D'Zurilla TJ. Problem-solving therapy for depres- sion: a meta-analysis. Clin Psychol Rev. 2009;29:348-353. source
- Interpretationcitation
Level 1 Evidence supports BA as a first-line treatment for acute depression.
“Overall, Level 1 Evidence supports BA as a first-line treatment for acute depression”
Quote in the paperSubstantial claim - Interpretationnone given
There is modest evidence that BA in acute depression provides protection against future relapse (Level 2).
“with modest evidence that BA in acute depression provides protection against future relapse (Level 2)”
Quote in the paperSubstantial claim - Premisecitation
Internet- and computer-delivered therapy (I/CT) can also be helpful in relapse prevention.
“Internet-and computer-delivered therapy (I/CT) can also be helpful in relapse prevention.151”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] 151. Holla ¨ndare F, Anthony SA, Randestad M, et al. Two- year outcome of Internet-based relapse prevention for partially remitted depression. Behav Res Ther. 2013;51: 719-722. source
- Premisecitation
A noninferiority study specifically for depression found no differences between guided Internet CBT and face-to-face CBT.
“while a noninferiority study 154 specifically for depression also found no differences between the 2 approaches.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [154] 154. Wagner B, Horn AB, Maercker A. Internet-based versus face- to-face cognitive-behavioral intervention for depression: a randomized controlled non-inferiority trial. J Affect Disord. 2014;152-154:113-121. source
- Premisecitation
Accumulated evidence shows that combined psychological and antidepressant treatment is more effective than psychological treatment alone or psychological treatment with placebo.
“Accumulated evidence shows that combined psychological and antidepressant treatment is more effective than psychological treatment alone or psychological treatment with placebo.159,160”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [159] 159. Cuijpers P, De Wit L, Weitz E, et al. The combination of psychotherapy and pharmacotherapy in the treatment of adult depression: a comprehensive meta-analysis. J Evid Based Psychother. 2015;15:147.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [160] 160. de Maat SM, Dekker J, Schoevers RA, et al. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry. 2007;22:1-8. source
- Premisecitation
A recent meta-analysis shows that psychological treatment combined with antidepressants is more effective than antidepressants alone.
“A recent meta-analysis shows that psychological treatment combined with antidepressants is more effective than antidepressants alone.159”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] 159. Cuijpers P, De Wit L, Weitz E, et al. The combination of psychotherapy and pharmacotherapy in the treatment of adult depression: a comprehensive meta-analysis. J Evid Based Psychother. 2015;15:147.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
There was a trend for SSRIs and IPT to be less effective in combinations than TCAs, CBT, and other psychotherapies.
“There was a trend for SSRIs and IPT to be less effective in combinations than TCAs, CBT, and other psychotherapies.”
Quote in the paperNot a substantial claim - Interpretationcitation
Level 1 Evidence supports CBT or MBCT as sequential first-line treatment after a course of antidepressants.
“In summary, CBT or MBCT is recommended as sequential first-line treatment (Level 1 Evidence) after a course of antidepressants”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [161] 161. Guidi J, Fava GA, Fava M, et al. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med. 2011;41:321-331. source
- cites [63] 63. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381: 375-384. source
- Premisecitation
A meta-analysis of 8 studies found that psychological treatment after antidepressant treatment reduces the likelihood of relapse by 20%, compared to treatment as usual, which included discontinuation of antidepressants.
“A meta-analysis of 8 studies found that psychological treatment after antidepressant treatment reduces the likelihood of relapse by 20%, compared to treatment as usual, which included discontinuation of antidepressants.161”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] 161. Guidi J, Fava GA, Fava M, et al. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med. 2011;41:321-331. source
- Classified as probably not a substantial claim. 7
- May combine two claims. 39
Classified as probably not a substantial claim.
InterpretationreasoningLevel 2 Evidence supports peer interventions as a second-line adjunctive treatment for MDD.
“peer interventions are recommended as a second-line adjunctive treatment for MDD (Level 2 Evidence).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [134] source
The Discussion and Conclusion report that peer support improves depressive symptoms compared with usual care and may be an effective component of depression care. They do not recommend it specifically as a second-line adjunctive treatment or assign it a “Level 2 Evidence” grade. The Results section also says trials studying peer support only as an add-on to depression care management were excluded. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [135] 135. Fuhr DC, Salisbury TT, De Silva MJ, et al. Effectiveness of peer-delivered interventions for severe mental illness and depression on clinical and psychosocial outcomes: a systematic review and meta-analysis. Soc Psychiatry Psy- chiatr Epidemiol. 2014;49:1691-1702. source
The Results section, ‘Effect of peer-delivered interventions on depression’ (page unavailable), reports no effect on clinical outcomes or loneliness compared with usual care. The paper does not assign a Level 2 evidence grade or recommend peer interventions as a second-line adjunctive treatment for MDD; its reported depression findings run contrary to that recommendation. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [136] 136. Valenstein M, Pfeiffer PN, Brandfon S, et al. Augmenting ongoing depression care with a mutual peer support interven- tion versus self-help materials alone: a randomized trial. Psy- chiatr Serv. 2016;67:236-239. source
The Methods describe testing peer support alongside ongoing depression treatment, so the paper supports its use as an adjunct in the trial. But the Results and Conclusions report no benefit over enhanced usual care; they do not recommend peer interventions as second-line treatment or assign a Level 2 evidence rating. The authors say other peer-support models might be more effective. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Rests on an assumption: Peer support can be beneficial either alone or as a complement to clinical care.
May combine two claims.
PremisecitationPsychological treatments benefit men and women to the same extent and are equally suitable for individuals of all ages, levels of education, and cultural and ethnic backgrounds.
“Psychological treatments benefit men and women to the same extent; psychological treatments are equally suitable for individuals of all ages, levels of education, and cultural and ethnic backgrounds.9”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [9] 9. Simon GE, Perlis RH. Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry. 2010;167:1445-1455. source
The Introduction says specific psychotherapies have success comparable to antidepressant medication as first-line treatment for moderate depression, supporting a general claim of benefit. It does not establish equal benefit for men and women or equal suitability across ages, education levels, and cultural or ethnic backgrounds; the sections on treatment selection instead discuss other patient characteristics. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn the presence of HIV, psychological treatments improve adherence to medical interventions as well as depression.
“importantly, improved adherence to medical interventions as well as improvement in depression.32”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [32] 32. Sin NL, DiMatteo MR. Depression treatment enhances adher- ence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47:259-269. source
May combine two claims.
PremisecitationTherapist experience, adherence, and ability to be responsive to individual patient differences are associated with better outcomes.
“Therapist experience, adherence, and ability to be responsive to individual patient differences are associated with better outcomes.54,55”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [54] 54. Fournier JC, DeRubeis RJ, Amsterdam J, et al. Gains in employ- ment status following antidepressant medication or cognitive therapy for depression. Br J Psychiatry. 2015;206:332-338. source
The Methods (Acute Treatment; page unavailable) say therapist qualifications and adherence were characterized elsewhere, but do not link either to outcomes. The Discussion (page unavailable) raises differences in therapists’ techniques only as an untested explanation for site differences. Searches for therapist experience, adherence, and responsiveness to individual patients found no passage establishing the claimed association. (LLM, conf=0.77)
Experimental — accuracy not yet measured - cites [55] 55. Johnsen TJ, Friborg O. The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: a meta- analysis. Psychol Bull. 2015;141:747-768. source
May combine two claims.
PremisecitationEven less-trained therapists can have efficacy in treating depression and may be the only source of treatment.
“although even less-trained therapists can have efficacy in treating depression and indeed may be the only source of treatment.56”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] 56. van Ginneken N, Tharyan P, Lewin S, et al. Non-specialist health worker interventions for the care of mental, neurologi- cal and substance-abuse disorders in low-and middle-income countries. Cochrane Database Syst Rev. 2013;11:CD009149. source
May combine two claims.
PremisecitationSome meta-analytic comparisons between specific models of psychological treatment have shown no significant differences in efficacy, while others have shown modest differences.
“Some meta-analytic comparisons between specific models of psychological treatment have shown no significant differences in efficacy, 57 with others showing modest differences.58”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [57] 57. Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013; 58:376-385. source
- cites [58] 58. Linde K, Ru ¨cker G, Sigterman K, et al. Comparative effec- tiveness of psychological treatments for depressive disorders in primary care: network meta-analysis. BMC Fam Pract. 2015;16:103. source
May combine two claims.
PremisecitationThe most recent large trial of CBASP (N=491 in 3 conditions) produced results inconsistent with previous results and do not support the efficacy of CBASP.
“results of the most recent large trial (N ¼ 491 in 3 conditions) are inconsistent with previous results and do not support the efficacy of CBASP.75”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [75] 75. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al. Cognitive behavioral analysis system of psychotherapy and brief sup- portive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009;66:1178-1188. source
The Results table lists 96 patients receiving medication alone, 195 receiving medication plus BSP, and 200 receiving medication plus CBASP—491 across three conditions. The Results discussion says adding CBASP did not significantly improve outcomes and that the findings contradicted predictions from previous studies. But the trial tested CBASP only as an addition to medication for chronically depressed patients who had not fully responded to initial medication; it does not establish a general lack of CBASP efficacy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationGroup therapy is less effective than individual therapy at the end of treatment and has a higher dropout rate, although no differences were found at follow-up.
“However, group therapy was less effective than individual therapy at the end of treatment and had a higher dropout rate, although no differences were found at follow-up.77”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [77] 77. Huntley AL, Araya R, Salisbury C. Group psychological therapies for depression in the community: systematic review and meta-analysis. Br J Psychiatry. 2012;200:184-190. source
The “Group CBT v. individual CBT therapy” section reports better outcomes for individual CBT immediately after treatment and no evidence of a difference at short- or longer-term follow-up. It does not report a higher dropout rate for group therapy; the “Individual CBT v. group CBT” section instead notes that four of seven studies gave no dropout details. The comparison also concerns CBT specifically, rather than group and individual therapy generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationUsing a different definition of bona-fide therapy, supportive therapy was less effective than other types of therapy, with no differences between CBT, IPT, and psychodynamic psychotherapy (PDT).
“using a different definition of bona-fide therapy, supportive therapy was less effective than other types of therapy, with no differences between CBT, IPT, and psychodynamic psychotherapy (PDT).60”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [60] 60. Braun SR, Gregor B, Tran US. Comparing bona fide psy- chotherapies of depression in adults with two meta- analytical approaches. PLoS One. 2013;8:e68135. source
The Results (Type I Meta-Analyses; page unavailable) report no efficacy difference among CBT, IPT, and psychodynamic therapy, and lower efficacy for some supportive-therapy subtypes on specific post-treatment measures. The Abstract (Results; page unavailable) says there were no significant differences at follow-up, while the Discussion describes the supportive-therapy finding as small and tentative. The claim omits those limits and states the lower efficacy categorically. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationSeveral meta-analyses demonstrate efficacy of MBCT, and a large, high-quality RCT (N=424) demonstrated equal efficacy of MBCT to medication as maintenance treatment for recurrent MDD.
“With several meta-analyses demonstrating efficacy 67,68 and a large, high-quality RCT (N ¼ 424) 69 demonstrating equal efficacy of MBCT to medication as maintenance treatment for recurrent MDD”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [67] 67. Galante J, Iribarren SJ, Pearce PF. Effects of mindfulness- based cognitive therapy on mental disorders: a systematic review and meta-analysis of randomised controlled trials. J Res Nurs. 2013;18:133-155. source
- cites [68] 68. Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depres- sive disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2011;31:1032-1040. source
- cites [69] 69. Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost- effectiveness of mindfulness-based cognitive therapy com- pared with maintenance antidepressant treatment in the pre- vention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386:63-73. source
The Results report that the trial recruited 424 patients, and the Discussion describes MBCT with support to taper antidepressants (MBCT-TS) as not superior to maintenance antidepressants over two years. The paper supports MBCT-TS as an alternative, but the trial did not establish equal efficacy; its finding of no superiority does not prove equivalence. The meta-analyses in the citing sentence have separate citations and are not judged here. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAn RCT of 469 primary care patients with depression with poor response to medication found CBT improved response and remission, with sustained effects at 3-year follow-up.
“An RCT of 469 primary care patients with depression with poor response to medication found CBT improved response and remission, 63 with sustained effects at 3-year follow-up.89”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [63] 63. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381: 375-384. source
- cites [89] 89. Wiles NJ, Thomas L, Turner N, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depres- sion in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry. 2016;3:137-144. source
May combine two claims.
InterpretationcitationThere is only weak evidence, and only after prolonged treatment, for efficacy of long-term PDT for acute treatment of MDD.
“However, there is only weak evidence, and only after prolonged treatment, for efficacy of long-term PDT for acute treatment of MDD.74,109”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [74] 74. Fonagy P, Rost F, Carlyle J, et al. Pragmatic randomized con- trolled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry. 2015;14:312-321. source
The Abstract says evidence for longer-term psychoanalytic treatment was at an early stage and suggests benefits particularly over longer follow-up. The Outcomes section reports no significant difference in partial remission at the end of treatment, with differences emerging during follow-up. However, this trial studied treatment-resistant depression, not acute treatment of MDD generally, so it does not support that broader setting. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [109] 109. Leichsenring F, Ablon S, Barber JP, et al. Developing a pro- totype for short-term psychodynamic (supportive-expressive) therapy: an empirical study with the psychotherapy process Q-set. Psychother Res. 2015;26:500-510. source
May combine two claims.
FindingcitationSince the first CBASP trial published in 2000, 5 CBASP studies have been published that provide only mixed results supporting CBASP.
“Since the first CBASP trial published in 2000, 114 5 CBASP studies have been published that provide only mixed results supporting CBASP.75,[115][116][117][118]”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [75] 75. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al. Cognitive behavioral analysis system of psychotherapy and brief sup- portive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009;66:1178-1188. source
The Results (Comment; page unavailable) say this trial found no added benefit from CBASP and that its findings contradicted previous studies, supporting the characterization of mixed results. The paper does not establish that exactly five CBASP studies had been published since the first trial in 2000. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [115] 115. Schatzberg AF, Rush AJ, Arnow BA, et al. Chronic depres- sion: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005; 62:513-520. source
- cites [116] 116. Schramm E, Zobel I, Dykierek P, et al. Cognitive behavioral analysis system of psychotherapy versus interpersonal psy- chotherapy for early-onset chronic depression: a randomized pilot study. J Affect Disord. 2011;129:109-116. source
May combine two claims.
PremisecitationClinical trials have supported MBCT's therapeutic value as an adjunct to treatment as usual and its comparability to maintenance antidepressant medication.
“Clinical trials have supported its therapeutic value as an adjunct to treatment as usual 94,95 and its comparability to maintenance antidepressant medication 69,96 in this context.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [94] 94. Bondolfi G, Jermann F, der Linden MV, et al. Depression relapse prophylaxis with mindfulness-based cognitive ther- apy: replication and extension in the Swiss health care system. J Affect Disord. 2010;122:224-231. source
- cites [95] 95. Godfrin KA, van Heeringen C. The effects of mindfulness- based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: a randomized controlled study. Behav Res Ther. 2010;48:738-746. source
- cites [69] 69. Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost- effectiveness of mindfulness-based cognitive therapy com- pared with maintenance antidepressant treatment in the pre- vention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386:63-73. source
May combine two claims.
PremisecitationAn initial meta-analysis of peer support for depression was positive, but subsequent results are mixed.
“An initial meta-analysis of peer support for depression was positive, but subsequent results are mixed.[134][135][136]”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [134] source
- cites [135] 135. Fuhr DC, Salisbury TT, De Silva MJ, et al. Effectiveness of peer-delivered interventions for severe mental illness and depression on clinical and psychosocial outcomes: a systematic review and meta-analysis. Soc Psychiatry Psy- chiatr Epidemiol. 2014;49:1691-1702. source
The Results section, ‘Effect of peer-delivered interventions on depression’ (page not provided), reports no significant effect on clinical outcomes or loneliness, supporting the claim that later findings were not uniformly positive. The Introduction mentions earlier reviews but does not say an initial meta-analysis of peer support for depression was positive. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [136] 136. Valenstein M, Pfeiffer PN, Brandfon S, et al. Augmenting ongoing depression care with a mutual peer support interven- tion versus self-help materials alone: a randomized trial. Psy- chiatr Serv. 2016;67:236-239. source
The paper’s discussion of prior evidence (page unavailable) says findings for peer-support interventions have been mixed, and its Results report no significant difference between its intervention and comparison groups. Its References list a meta-analysis of peer support for depression, but the available text does not say that the meta-analysis was positive. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationBoth telephone-delivered and in-person PST were effective for treating MDD in low-income homebound older adults.
“Both telephone-delivered and in-person PST were effective for treating MDD in low-income homebound older adults.139”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [139] 139. Choi NG, Marti CN, Bruce ML, et al. Six-month postinter- vention depression and disability outcomes of in-home tele- health problem-solving therapy for depressed, low-income homebound older adults. Depress Anxiety. 2014;31:653-661. source
The Discussion (page not available) reports that both tele-PST and in-person PST were effective for depression in low-income homebound older adults. But the Intervention section specifies that tele-PST used Skype video calls, not telephone delivery; telephone calls were a separate support-only comparison group. The Participants and Settings section defines eligibility by a depression-rating score, rather than an MDD diagnosis. (LLM, conf=0.92)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn 16 studies of various diagnoses, there was improvement in depressive symptoms and anxiety with ACT, although less than with CBT.
“In 16 studies of various diagnoses, there was improvement in depressive symptoms and anxiety with ACT, although less than with CBT.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [120] 120. Powers MB, Zum Vorde Sive Vording MB, Emmelkamp PMG. Acceptance and commitment therapy: a meta- analytic review. Psychother Psychosom. 2009;78:73-80. source
- cites [121] 121. Ruiz FJ. Acceptance and commitment therapy versus tradi- tional cognitive behavioral therapy: a systematic review and meta-analysis of current empirical evidence. Int J Psychol Psychol Ther. 2012;12:333-357.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [122] 122. A-Tjak JGL, Davis ML, Morina N, et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clini- cally relevant mental and physical health problems. Psy- chother Psychosom. 2015;84:30-36. source
The Effect Size as a Function of Target Problem section reports better anxiety/depression outcomes with ACT than with control conditions, supporting the improvement claim. But this paper analyzed 39 trials, not 16; its Discussion identifies 16 as the number in a separate meta-analysis by Ruiz. The Discussion also reports no significant difference between ACT and established treatments such as CBT, with effect sizes appearing slightly larger for ACT—not less improvement than with CBT. Page numbers were not available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe broader application of videoconferencing technologies to psychiatry has been extensively reviewed and found to be acceptable and generally equivalent to face-to-face care for many psychiatric conditions.
“The broader application of such technologies to psychiatry has been extensively reviewed and found to be acceptable and generally equivalent to face-to-face care for many psychiatric conditions. 155,,156”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [155] 155. Gajaria A, Conn DK, Madan R. Telepsychiatry: effectiveness and feasibility. Smart Homecare Technol TeleHealth. 2015; 2015:59-67. source
Checked before — its earlier verdict is held back until a new check runs.
- cites [156] 156. Chakrabarti S. Usefulness of telepsychiatry: a critical evalua- tion of videoconferencing-based approaches. World J Psy- chiatry. 2015;5:286-304. source
May combine two claims.
PremisecitationAnother large primary care trial compared the effects of group MBCT and maintenance antidepressant therapy on time to relapse; while there were no significant differences between the 2 conditions, the risk of relapse was greater in those who had prematurely discontinued antidepressant treatment.
“Another large primary care trial compared the effects of group MBCT and maintenance antidepressant therapy on time to relapse; while there were no significant differences between the 2 conditions, the risk of relapse was greater in those who had prematurely discontinued antidepressant treatment.69”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [69] 69. Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost- effectiveness of mindfulness-based cognitive therapy com- pared with maintenance antidepressant treatment in the pre- vention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386:63-73. source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
FindingreasoningCBT remains the most established evidence-based, first-line treatment for depression, both acute and maintenance.
“CBT remains the most established evidence-based, first-line treatment for depression, both acute and maintenance.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenA key limitation of the STPP literature is the conflation of different models of psychodynamic therapy (PDT) into the broad term STPP, whereby no single model has a replicated large RCT with positive findings for MDD, unlike CBT and IPT.
“A key limitation of the STPP literature is the conflation of different models of psychodynamic therapy (PDT) into the broad term STPP, whereby no single model has a replicated large RCT with positive findings for MDD, unlike CBT and IPT.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenVery few bibliotherapy trials have been published since 2009.
“very few bibliotherapy trials have been published since 2009.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenPST has been tested most extensively in primary care settings in individuals with a variety of depressive symptoms spanning subclinical depression, adjustment disorders, and MDD, with clear efficacy in reducing depressive symptoms.
“PST has been tested most extensively in primary care settings in individuals with a variety of depressive symptoms spanning subclinical depression, adjustment disorders, and MDD, with clear efficacy in reducing depressive symptoms.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAlthough the meta-analysis aimed to examine the effect of any type of psychological treatment, the evidence was limited to CBT and MBCT.
“Although the meta-analysis aimed to examine the effect of any type of psychological treatment, the evidence was limited to CBT and MBCT.161”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] 161. Guidi J, Fava GA, Fava M, et al. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med. 2011;41:321-331. source
May combine two claims.
PremisecitationRecruitment of individuals in standard MDD RCTs often excludes people with current suicidality, substance use, and other comorbidities, which limits the generalizability of these studies.
“recruitment of individuals in standard MDD RCTs often excludes people with current suicidality, substance use, and other comorbidities.5 This limits the generalizability of these studies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] 5. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159:469-473. source
May combine two claims.
PremisecitationMen and women derive similar benefits from CBT and from antidepressants.
“a large individual-level meta-analysis confirmed that men and women derive similar benefits from CBT and from antidepressants.11”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] 11. Cuijpers P, Weitz E, Twisk J, et al. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an ''individual patient data'' meta-analysis. Depress Anxiety. 2014;31: 941-951. source
May combine two claims.
PremisecitationFor ADHD, CBT can improve both depressive and ADHD symptoms.
“For ADHD, CBT can improve both depressive and ADHD symptoms.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] 22. Bond DJ, Hadjipavlou G, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention- deficit/hyperactivity disorder. Ann Clin Psychiatry. 2012; 24:23-37. source
Classified as probably not a substantial claim.
PremisecitationThe best outcomes are likely to come from the concurrent use of evidence-based therapy relationships, not just evidence-based treatments.
“concluded that the best outcomes are likely to come from the concurrent use of evidence-based therapy relationships, not just evidence-based treatments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] 45. Norcross JC.Psychotherapy relationships that work: evidence-based responsiveness. 2nd ed. New York (NY): Oxford University Press; 2011.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThree evidence-based common factors found to predict positive outcomes are establishing a strong therapeutic alliance, using empathy, and collecting client feedback.
“Three evidence-based common factors found to predict positive outcomes are establishing a strong therapeutic alliance, using empathy, and collecting client feedback (Table 4).[46][47][48][49]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [46] 46. Norcross JC, Lambert MJ. Psychotherapy relationships that work II. Psychotherapy. 2011;48:4-8. source
- cites [47] 47. Norcross JC, Wampold BE. Evidence-based therapy relation- ships: research conclusions and clinical practices. Psychother- apy. 2011;48:98-102. source
- cites [48] 48. Elliott R, Bohart AC, Watson JC, et al. Empathy. Psychother- apy (Chic). 2011;48:43-49. source
May combine two claims.
PremisecitationMany pregnant women prefer psychological treatment and report fear of potential adverse effects of antidepressants on the developing fetus or newborn via lactation, general worries about negative outcome, fears of dependency, and balancing concerns about their own health or the fetus.
“many pregnant women prefer psychological treatment and report fear of potential adverse effects of antidepressants on the developing fetus or on their newborn via lactation, general worries about a negative outcome, and fears of dependency as well as balancing concerns about their own health or the fetus.41,42”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] 41. Battle CL, Salisbury AL, Schofield CA, et al. Perinatal anti- depressant use: understanding women's preferences and con- cerns. J Psychiatr Pract. 2013;19:443-453. source
- cites [42] 42. Walton GD, Ross LE, Stewart DE, et al. Decisional con- flict among women considering antidepressant medication use in pregnancy. Arch Womens Ment Health. 2014;17: 493-501. source
May combine two claims.
PremisecitationWhen only bona-fide therapies were considered, there were no differences between CBT and IPT, but CBT was more effective than other psychotherapies considered as a group.
“When only bona-fide therapies (defined as delivered by trained therapists, based on psychological principles, and designed to be a viable treatment) were considered, there were no differences between CBT and IPT, but CBT was more effective than other psychotherapies considered as a group 59”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] 59. Tolin DF. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clin Psychol Rev. 2010;30:710-720. source
May combine two claims.
PremisecitationThe evidence base for STPP has expanded with recent studies, including comparisons with CBT and antidepressant medication and a recently updated meta-analysis.
“The evidence base for STPP has expanded with recent studies, including comparisons with CBT 72 and antidepressant medication 73 and a recently updated meta-analysis.61”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [72] 72. Driessen E, Van HL, Don FJ, et al. The efficacy of cognitive- behavioral therapy and psychodynamic therapy in the outpa- tient treatment of major depression: a randomized clinical trial. Am J Psychiatry. 2013;170:1041-1050. source
- cites [73] 73. Barber JP, Barrett MS, Gallop R, et al. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psy- chiatry. 2012;73:66-73. source
- cites [61] 61. Driessen E, Hegelmaier LM, Abbass AA, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev. 2015;42:1-15. source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningGiven the gap between needed and available psychological treatments, group psychotherapy could improve access to treatment.
“given the gap between needed and available psychological treatments, group psychotherapy could improve access to treatment.”
Quote in the paperNot a substantial claim- Rests on an assumption: There is a gap between needed and available psychological treatments.
May combine two claims.
PremisecitationStudies comparing 8 versus 16 or more sessions are rare but suggestive of similar effectiveness.
“Studies comparing 8 versus 16 or more sessions are rare but suggestive of similar effectiveness.[84][85][86]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [84] 84. Dekker J, Molenaar PJ, Kool S, et al. Dose-effect relations in time-limited combined psycho-pharmacological treatment for depression. Psychol Med. 2005;35:47-58. source
- cites [85] 85. Molenaar PJ, Boom Y, Peen J, et al. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning? Br J Clin Psychol. 2011;50:268-282. source
- cites [86] 86. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and anti- depressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006; 74:658-670. source
May combine two claims.
PremisecitationA meta-analysis of 10 trials demonstrated a reduction in the risk of relapse by 21% in the first year and by 28% in the first 2 years.
“A meta-analysis of 10 trials demonstrated a reduction in the risk of relapse by 21% in the first year and by 28% in the first 2 years.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] 90. Clarke K, Mayo-Wilson E, Kenny J, et al. Can non- pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2015;39:58-70. source
May combine two claims.
InterpretationreasoningThere is insufficient evidence to recommend STPP or PDT as a maintenance treatment for MDD.
“There is insufficient evidence to recommend STPP or PDT as a maintenance treatment for MDD.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCBASP was developed specifically for the treatment of chronic depression.
“CBASP was developed specifically for the treatment of chronic depression.113”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] 113. McCullough JP. Treatment for chronic depression using cog- nitive behavioral analysis system of psychotherapy (CBASP). J Clin Psychol. 2003;59:833-846. source
May combine two claims.
PremisecitationTwo separate meta-analyses found that the use of PST as an acute treatment for late life depression resulted in a significant reduction of depressive symptoms as well as disability in comparison to control treatments.
“Two separate meta-analyses found that the use of PST as an acute treatment for late life depression resulted in a significant reduction of depressive symptoms as well as disability in comparison to control treatments.138,140”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [138] 138. Bell AC, D'Zurilla TJ. Problem-solving therapy for depres- sion: a meta-analysis. Clin Psychol Rev. 2009;29:348-353. source
- cites [140] 140. Kirkham JG, Choi N, Seitz DP. Meta-analysis of problem solving therapy for the treatment of major depressive disorder in older adults. Int J Geriatr Psychiatry. 2015;31:526-535. source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationThe rationale for BA is that depression is caused and maintained by escape and avoidance of aversive emotions and stimuli that become self-reinforced and also prevents positive reinforcement of nondepressive behaviour, consequently causing longstanding patterns of inertia, avoidance, and social withdrawal.
“The rationale for BA is that depression is caused and maintained by escape and avoidance of aversive emotions and stimuli that become self-reinforced and also prevents positive reinforcement of nondepressive behaviour, consequently causing longstanding patterns of inertia, avoidance, and social withdrawal.123”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [123] 123. Ferster CB. A functional analysis of depression. Am Psychol. 1973;28:857-870. source
May combine two claims.
PremisecitationOne meta-analysis (34 studies, N > 2000 patients with depressive symptoms, but not necessarily MDD) found similar large effect sizes for BA and CBT compared to control conditions, as well as a similar effect to CBT.
“One meta-analysis (34 studies, N > 2000 patients with depressive symptoms, but not necessarily MDD) 127 found similar large effect sizes for BA and CBT compared to control conditions, as well as a similar effect to CBT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] 127. Mazzucchelli T, Kane R, Rees C. Behavioral activation treat- ments for depression in adults: a meta-analysis and review. Clin Psychol Sci Pract. 2009;16:383-411. source
Classified as probably not a substantial claim.
InterpretationreasoningLevel 2 Evidence supports PST as a second-line acute treatment in primary care and geriatric depression.
“PST is recommended as a second-line acute treatment in primary care and geriatric depression (Level 2 Evidence)”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationTelephone-delivered CBT has Level 1 Evidence, while other therapies have Level 2 Evidence.
“Collectively, telephone-delivered CBT has Level 1 Evidence, while other therapies have Level 2 Evidence”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn one of the first large trials (600 patients starting antidepressants in primary care offices), both 8-session CBT and disease management by phone improved clinical efficacy and satisfaction, compared to medication alone.
“In one of the first large trials (600 patients starting antidepressants in primary care offices), both 8-session CBT and disease management by phone improved clinical efficacy and satisfaction, compared to medication alone.79”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] 79. Simon GE, Ludman EJ, Tutty S, et al. Telephone psychother- apy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004;292:935-942. source
May combine two claims.
PremisecitationA large pragmatic trial found that a course of up to 18 sessions of face-to-face individual CBT significantly reduced depressive symptoms and increased the likelihood of therapeutic response to antidepressants in treatment-resistant depression.
“a large pragmatic trial found that a course of up to 18 sessions of face-to-face individual CBT significantly reduced depressive symptoms and increased the likelihood of therapeutic response to antidepressants in treatment-resistant depression.63”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] 63. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381: 375-384. source
May combine two claims.
PremisecitationWhen Internet therapy is guided by a clinician, both adherence and efficacy are much more substantial.
“When the Internet therapy is guided by a clinician, both adherence and efficacy are much more substantial.88”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] 88. Cuijpers P. Psychotherapies for adult depression: recent developments. Curr Opin Psychiatry. 2015;28:24-29. source
The paper relies on this without support.
Older patients with depression are more vulnerable to medication side effects and drug interactions because many may already be taking multiple medications for comorbid medical disorders.
“older patients with depression are more vulnerable to medication side effects and drug interactions, as many may already be taking multiple medications for comorbid medical disorders.”
The paper relies on this without support.
The evidence for psychological therapies for depression is based on studies with highly competent therapists.
“Most importantly, the evidence for psychological therapies for depression is based on studies with highly competent therapists”
The paper relies on this without support.
All high-quality evidence in psychotherapy research is based on studies where extensively trained therapists receive regular supervision and adhere to principles of the given therapeutic model with high fidelity.
“All high-quality evidence in psychotherapy research is based on studies where extensively trained therapists receive regular supervision and adhere to principles of the given therapeutic model with high fidelity.”
The paper relies on this without support.
Comparisons of different psychological treatments are fewer in number and quality, and are complicated by methodological challenges including lack of blinding and allegiance to a particular model.
“Comparisons of different psychological treatments are fewer in number and quality, as well as complicated by methodological challenges, including lack of blinding and the effects of allegiance to a particular model.”
The paper relies on this without support.
There is a gap between needed and available psychological treatments.
“given the gap between needed and available psychological treatments”
The paper relies on this without support.
The core of psychotherapy remains unchanged when delivered in a group format.
“the core of the psychotherapy remains unchanged, so group interventions are not evaluated in these guidelines as a separate ''group therapy.''”
The paper relies on this without support.
Context-specific therapies do not generalize to the average person with depression.
“context-specific therapies (such as marital therapy for MDD coinciding with a severe marital dispute) are not evaluated, since such therapies do not generalize to the average person with depression.”
The paper relies on this without support.
MI has been used in conjunction with CBT, IPT, or medications to improve treatment engagement or adherence and for treatment of depression and comorbid substance misuse.
“it has been used in conjunction with CBT, IPT, or medications to improve treatment engagement or adherence and for treatment of depression and comorbid substance misuse.”
The paper relies on this without support.
Peer support can be beneficial either alone or as a complement to clinical care.
“Peer support can be beneficial either alone or as a complement to clinical care.”
The paper relies on this without support.
Bibliotherapy has practical utility due to ease of use and low cost.
“bibliotherapy has practical utility due to ease of use and low cost”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MBCT is recommended in national clinical guidelines for relapse prevention in several countries and has been endorsed by the American Psychiatric Association.
“As such, MBCT is included in the clinical guidelines as a recommended option for relapse prevention in a number of different countries, including the UK, Netherlands, Canada, Australia and New Zealand (Malhi et al. 2015; NICE 2009; Parikh et al. 2016), and has been endorsed by the American Psychiatric Association (Lu 2015).”
From The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services (2020) · cites this paper as Parikh et al. 2016
Individuals with inflammatory and metabolic comorbidities have greater risks of mood disorders and cognitive dysfunction.
“Indeed, individuals with inflammatory and metabolic comorbidities are at greater risks of mood disorders and cognitive dysfunction.13,14”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [14]
A recent meta-analysis showed that reductions in cognitive function predict poorer functional and metabolic outcomes.
“Moreover, evidence from a recent meta-analysis showed that reductions in cognitive function are predictive of poorer functional and metabolic outcomes.14”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [14]
CBT is the first-line psychological treatment recommended by guidelines for depression, anxiety, and PTSD.
“CBT is the first-line psychological treatment recommended by the guidelines of depression, anxiety, and PTSD (ie, Canadian Network for Mood and Anxiety Treatments and National Institute of Health and Care Excellence guideline [49,50].”
From The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial (2021) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting maintenance recommendation for long-term psychodynamic therapy
MajorThe text says there is insufficient evidence to recommend psychodynamic therapy for maintenance treatment, but Table 5 gives long-term psychodynamic therapy a third-line maintenance recommendation.
“There is insufficient evidence to recommend STPP or PDT as a maintenance treatment for MDD.”
“| Long-term psychodynamic | Third line | Third line (Level 3) | | psychotherapy (PDT) | (Level 3) | |”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1001/jamapsychiatry.2014.1054
InfoThe cited work was retracted; the date of the notice is not on record.
Cited work 10.1001/jamapsychiatry.2014.1054 · retraction date not known · this paper published 2016-08-11
“10.1001/jamapsychiatry.2014.1054”
Cites
1 retracted
Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., Young, P. R., & Gallop, R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1054 · Cited by 179 · see citing works
RetractedThe PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · see citing works
Acceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 1× · see citing works
“The aim of ACT is to mindfully increase acceptance of distressing experiences by taking an observer perspective and by clarifying and orienting behaviour towards valued directions, instead of struggling against or trying to control perceived suffering.(119) Since 2009, there have been 3 meta-analyses with a comparison…”
BackgroundRossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367 · see citing works
(2001) · Cited by 3,666 · see citing works
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · see citing works
(2013) · Cited by 2,393 · see citing works
Alliance in individual psychotherapy
Horvath, A. O., Del Re, A. C., Flückiger, C., & Symonds, D. (2011) · Psychotherapy · doi:10.1037/a0022186 · Cited by 2,072 · see citing works
Transcranial magnetic stimulation: a primer.
Hallett, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.026 · Cited by 1,886 · see citing works
Physiological basis of transcranial direct current stimulation
Stagg, C. J., & Nitsche, M. A. (2011) · The Neuroscientist · doi:10.1177/1073858410386614 · Cited by 1,719 · see citing works
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607 · see citing works
Computer-based psychological treatments for depression: A systematic review and meta-analysis
Richards, D., & Richardson, T. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.02.004 · Cited by 1,442 · see citing works
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390 · see citing works
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · see citing works
Andrews, G., Cuijpers, P., Craske, M. G., McEvoy, P., & Titov, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013196 · Cited by 1,311 · see citing works
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQUEEN, G. M., McIntyre, R. S., Sharma, V., et al. (2012) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,209 · see citing works
Self-citationA Meta-Analysis of Motivational Interviewing: Twenty-Five Years of Empirical Studies
Lundahl, B. W., Kunz, C., Brownell, C., Tollefson, D., & Burke, B. L. (2010) · Research on Social Work Practice · doi:10.1177/1049731509347850 · Cited by 1,086 · see citing works
Andersson, G., Cuijpers, P., Carlbring, P., Riper, H., & Hedman, E. (2014) · World Psychiatry · doi:10.1002/wps.20151 · Cited by 1,077 · see citing works
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · see citing works
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056 · see citing works
Behavioral activation treatment for depression: returning to contextual roots
Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.8.3.255 · Cited by 1,011 · see citing works
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · see citing works
Psychotherapy Relationships That Work
Norcross, J. C. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199737208.001.0001 · Cited by 950 · see citing works
A-Tjak, J. G. L., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A. J., & Emmelkamp, P. M. G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000365764 · Cited by 921 · cited 1× · see citing works
“ACT may also have particular value in the presence of comorbid medical conditions.(122) In the absence of specific large trials in MDD, evidence remains at Level 3 and ACT is recommended as a third-line treatment for MDD.”
BackgroundA functional analysis of depression.
Ferster, C. B. (1973) · American Psychologist · doi:10.1037/h0035605 · Cited by 918 · see citing works
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · see citing works
Safran, J. D., Muran, J. C., & Eubanks-Carter, C. (2011) · Psychotherapy · doi:10.1037/a0022140 · Cited by 823 · see citing works
Evidence-based therapy relationships: Research conclusions and clinical practices.
Norcross, J. C., & Wampold, B. E. (2011) · Psychotherapy · doi:10.1037/a0022161 · Cited by 813 · see citing works
Piet, J., & Hougaard, E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.05.002 · Cited by 807 · see citing works
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800 · see citing works
Psychotherapy relationships that work II.
Norcross, J. C., & Lambert, M. J. (2011) · Psychotherapy · doi:10.1037/a0022180 · Cited by 797 · see citing works
Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770 · see citing works
Semkovska, M., & McLoughlin, D. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.009 · Cited by 718 · see citing works
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686 · see citing works
Probing and regulating dysfunctional circuits using deep brain stimulation
Lozano, A. M., & Lipsman, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.020 · Cited by 665 · see citing works
Shimokawa, K., Lambert, M. J., & Smart, D. W. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0019247 · Cited by 657 · see citing works
Is cognitive–behavioral therapy more effective than other therapies?
Tolin, D. F. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.05.003 · Cited by 645 · see citing works
Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000512 · Cited by 620 · see citing works
Acceptance and commitment therapy: A meta-analytic review
Powers, M. B., Zum Vörde Sive Vörding, M. B., & Emmelkamp, P. M. G. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000190790 · Cited by 619 · see citing works
A Brief Behavioral Activation Treatment for Depression: Treatment Manual
Lejuez, C. W., Hopko, D. R., & Hopko, S. D. (2001) · Behavior Modification · doi:10.1177/0145445501252005 · Cited by 611 · see citing works
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608 · see citing works
The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study
Brunoni, A. R., Valiengo, L. D. C. L., Baccaro, A., Zanao, T. A., de Oliveira, J. F., Goulart, A. C., Boggio, P. S., Lotufo, P. A., Benseñor, I. M., & Fregni, F. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.32 · Cited by 598 · see citing works
The Dodo bird verdict is alive and well-mostly.
Luborsky, L., Rosenthal, R., Diguer, L., Andrusyna, T. P., Berman, J. S., Levitt, J. T., Seligman, D. A., & Krause, E. D. (2002) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.9.1.2 · Cited by 581 · see citing works
van Ginneken, N., Tharyan, P., Lewin, S., Rao, G. N., Meera, S., Pian, J., Chandrashekar, S., & Patel, V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009149.pub2 · Cited by 575 · see citing works
Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., Jüni, P., & Cuijpers, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001454 · Cited by 569 · see citing works
Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D., & Gilbody, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100100 · Cited by 565 · see citing works
Rapid effects of deep brain stimulation for treatment-resistant major depression
Schlaepfer, T. E., Bewernick, B. H., Kayser, S., Mädler, B., & Coenen, V. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.034 · Cited by 563 · see citing works
Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Howland, R. H., Bhati, M. T., O’Reardon, J. P., Eskandar, E. N., Baltuch, G. H., Machado, A. D., Kondziolka, D., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.023 · Cited by 558 · see citing works
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., Lewis, G., Watkins, E., Brejcha, C., Cardy, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62222-4 · Cited by 527 · see citing works
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 526 · see citing works
Self-citationMeta-analysis: Its strengths and limitations
WALKER, E., HERNANDEZ, A. V., & KATTAN, M. W. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.6.431 · Cited by 519 · see citing works
Interpersonal Psychotherapy for Depression: A Meta-Analysis
Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10101411 · Cited by 511 · see citing works
Elliott, R., Bohart, A. C., Watson, J. C., & Greenberg, L. S. (2011) · Psychotherapy · doi:10.1037/a0022187 · Cited by 511 · see citing works
Nemeroff, C. B., Mayberg, H. S., Krahl, S. E., McNamara, J., Frazer, A., Henry, T. R., George, M. S., Charney, D. S., & Brannan, S. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301082 · Cited by 496 · see citing works
Efficacy of peer support interventions for depression: a meta-analysis
Pfeiffer, P. N., Heisler, M., Piette, J. D., Rogers, M. A. M., & Valenstein, M. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.10.002 · Cited by 484 · see citing works
The efficacy of Acceptance and Commitment Therapy: An updated systematic review and meta-analysis
Öst, L.-G. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.018 · Cited by 476 · see citing works
Kellner, C. H., Knapp, R. G., Petrides, G., Rummans, T. A., Husain, M. M., Rasmussen, K., Mueller, M., Bernstein, H. J., O’Connor, K., Smith, G., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1337 · Cited by 471 · see citing works
Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., Ramin, S., Chaudron, L., & Lockwood, C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.04.003 · Cited by 469 · see citing works
van der Velden, A. M., Kuyken, W., Wattar, U., Crane, C., Pallesen, K. J., Dahlgaard, J., Fjorback, L. O., & Piet, J. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.001 · Cited by 455 · see citing works
Problem-solving therapy for depression: A meta-analysis
Bell, A. C., & D'Zurilla, T. J. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.02.003 · Cited by 448 · see citing works
Behavioral activation treatments for depression in adults: A meta-analysis and review.
Mazzucchelli, T., Kane, R., & Rees, C. (2009) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.2009.01178.x · Cited by 438 · see citing works
Piet, J., Würtzen, H., & Zachariae, R. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028329 · Cited by 436 · see citing works
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial
Kellner, C. H., Knapp, R., Husain, M. M., Rasmussen, K., Sampson, S., Cullum, M., McClintock, S. M., Tobias, K. G., Martino, C., Mueller, M., et al. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.066183 · Cited by 432 · see citing works
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429 · see citing works
Self-citationWilliams, J. M. G., Crane, C., Barnhofer, T., Brennan, K., Duggan, D. S., Fennell, M. J. V., Hackmann, A., Krusche, A., Muse, K., Von Rohr, I. R., et al. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035036 · Cited by 420 · see citing works
Brunoni, A. R., Moffa, A. H., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, E., Alonzo, A., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.164715 · Cited by 414 · see citing works
The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update
Driessen, E., Hegelmaier, L. M., Abbass, A. A., Barber, J. P., Dekker, J. J. M., Van, H. L., Jansma, E. P., & Cuijpers, P. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.07.004 · Cited by 409 · see citing works
Sockol, L. E. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.052 · Cited by 395 · see citing works
Simon, G. E., Ludman, E. J., Tutty, S., Operskalski, B., & Korff, M. V. (2004) · JAMA · doi:10.1001/jama.292.8.935 · Cited by 395 · see citing works
Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.469 · Cited by 382 · see citing works
Carpenter, L. L., Janicak, P. G., Aaronson, S. T., Boyadjis, T. A., Brock, D. G., Cook, I. A., Dünner, D. L., Lanocha, K. I., Solvason, H. B., & Demitrack, M. A. (2012) · Depression and Anxiety · doi:10.1002/da.21969 · Cited by 371 · see citing works
Personalized Medicine for Depression: Can We Match Patients With Treatments?
Simon, G. E., & Perlis, R. H. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111680 · Cited by 365 · cited 2× · see citing works
“Psychological treatments in general and cognitive-behavioural therapy (CBT) in particular appear to be equally effective for different subtypes of depression, including atypical depression, melancholic depression, and anxious depression.(9,10) In addition, a large individual-level meta-analysis confirmed that men and…”
BackgroundDeep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6Years
Ballenger, J. C. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2011.08.041 · Cited by 365 · see citing works
Gaynes, B. N., Lloyd, S. W., Lux, L., Gartlehner, G., Hansen, R. A., Brode, S., Jonas, D. E., Evans, T. S., Viswanathan, M., & Lohr, K. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08815 · Cited by 347 · see citing works
Bower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D. A., Gilbody, S., Knowles, S., Cuijpers, P., Andersson, G., Christensen, H., et al. (2013) · BMJ · doi:10.1136/bmj.f540 · Cited by 341 · see citing works
Wiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., Garland, A., Hollinghurst, S., Jerrom, B., Kessler, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61552-9 · Cited by 340 · cited 2× · see citing works
“With more than 40 original reports and meta-analyses published on CBT for MDD or PDD since 2009, there is substantial evidence of efficacy even in severely affected individuals and in those who had not responded to treatment with antidepressants.(62,63) Similarly, there is evidence across populations (adult, adolescen…”
BackgroundDownar, J. H., Geraci, J., Salomons, T. V., Dunlop, K., Wheeler, S. M., McAndrews, M. P., Bakker, N., Blumberger, D. M., Daskalakis, Z. J., Kennedy, S. H., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.026 · Cited by 338 · see citing works
Self-citationBehavioral Activation for Depression: A Clinician's Guide
Dahl, J. C. (2010) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2010.514119 · Cited by 334 · see citing works
Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, M. H., Luther, J. F., Fava, M., Nierenberg, A. A., McGrath, P. J., Warden, D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.739 · Cited by 332 · see citing works
Johnsen, T. J., & Friborg, O. (2015) · Psychological Bulletin · doi:10.1037/bul0000015 · Cited by 331 · see citing works
Arnberg, F. K., Linton, S. J., Hultcrantz, M., Heintz, E., & Jonsson, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098118 · Cited by 330 · see citing works
Li, C.-T., Chen, M.-H., Juan, C.-H., Huang, H.-H., Chen, L.-F., Hsieh, J.-C., Tu, P.-C., Bai, Y.-M., Tsai, S.-J., Lee, Y.-C., et al. (2014) · Brain · doi:10.1093/brain/awu109 · Cited by 328 · see citing works
HIV and Depression – a systematic review of interventions
Sherr, L., Clucas, C., Harding, R., Sibley, E., & Catalan, J. (2011) · Psychology, Health & Medicine · doi:10.1080/13548506.2011.579990 · Cited by 325 · see citing works
Elkin, I., Gibbons, R. D., Shea, M. T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., & Hedeker, D. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.5.841 · Cited by 317 · see citing works
Elkin, I., Gibbons, R. D., Shea, M. T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., & Hedeker, D. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.5.841 · Cited by 317 · see citing works
Wagner, B., Horn, A. B., & Maercker, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.032 · Cited by 311 · see citing works
Response of Depression to Electroconvulsive Therapy
Haq, A. U., Sitzmann, A. F., Goldman, M. L., Maixner, D. F., & Mickey, B. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09528 · Cited by 310 · see citing works
Bakker, N., Shahab, S., Giacobbe, P., Blumberger, D. M., Daskalakis, Z. J., Kennedy, S. H., & Downar, J. (2015) · Brain Stimulation · doi:10.1016/j.brs.2014.11.002 · Cited by 306 · see citing works
Self-citationSalomons, T. V., Dunlop, K., Kennedy, S. H., Flint, A., Geraci, J., Giacobbe, P., & Downar, J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.222 · Cited by 299 · see citing works
Self-citationBerlim, M. T., den Eynde, F. V., & Daskalakis, Z. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.237 · Cited by 299 · see citing works
Godfrin, K. A., & van Heeringen, C. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.006 · Cited by 296 · see citing works
Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches
Chakrabarti, S. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i3.286 · Cited by 292 · cited 1× · see citing works
“The broader application of such technologies to psychiatry has been extensively reviewed and found to be acceptable and generally equivalent to face-to-face care for many psychiatric conditions.(155,156) Relatively few studies have been done using videoconferencing for MDD, but there is limited evidence of efficacy in…”
BackgroundCognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators
Driessen, E., & Hollon, S. D. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.005 · Cited by 291 · see citing works
Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
McCullough, J. P. (2003) · Journal of Clinical Psychology · doi:10.1002/jclp.10176 · Cited by 288 · see citing works
Lam, R. W., McIntosh, D., Wang, J., Enns, M. W., Kolivakis, T., Michalak, E. E., Sareen, J., Song, W.-Y., Kennedy, S. H., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659416 · Cited by 288 · see citing works
Self-citationRelapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis
Jelovac, A., Kolshus, E., & McLoughlin, D. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.149 · Cited by 287 · see citing works
Cape, J., Whittington, C., Buszewicz, M., Wallace, P., & Underwood, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-38 · Cited by 283 · see citing works
Shiozawa, P., Fregni, F., Benseñor, I. M., Lotufo, P. A., Berlim, M. T., Daskalakis, J. Z., Cordeiro, Q., & Brunoni, A. R. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000418 · Cited by 282 · see citing works
Behavioural activation for depression
Veale, D. (2008) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004051 · Cited by 282 · see citing works
Ross, L. E., Grigoriadis, S., Mamisashvili, L., VonderPorten, E. H., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.684 · Cited by 268 · see citing works
Self-citationDepression Treatment Enhances Adherence to Antiretroviral Therapy: a Meta-Analysis
Sin, N. L., & DiMatteo, M. R. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9559-6 · Cited by 266 · see citing works
Serotonin Affects Transcranial Direct Current–Induced Neuroplasticity in Humans
Nitsche, M. A., Kuo, M., Karrasch, R., Wächter, B., Liebetanz, D., & Paulus, W. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.022 · Cited by 265 · see citing works
(2012) · Re-Unir (International University of La Rioja) · Cited by 262 · see citing works
van Aalderen, J. R., Donders, A. R. T., Giommi, F., Spinhoven, P., Barendregt, H. P., & Speckens, A. E. M. (2012) · Psychological Medicine · doi:10.1017/s0033291711002054 · Cited by 262 · see citing works
How much psychotherapy is needed to treat depression? A metaregression analysis
Cuijpers, P., Huibers, M., Daniel Ebert, D., Koole, S. L., & Andersson, G. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.030 · Cited by 258 · see citing works
MacQUEEN, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M. S., Lieshout, R. J. V., Kennedy, S. H., Lam, R. W. M., Milev, R. V., Parikh, S. V., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659276 · Cited by 251 · see citing works
Self-citationDriessen, E., Van, H. L., Don, F. J., Peen, J., Kool, S., Westra, D., Hendriksen, M., Schoevers, R. A., Cuijpers, P., Twisk, J. W. R., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070899 · Cited by 241 · see citing works
Clinician's Quick Guide to Interpersonal Psychotherapy
Weissman, M. M., Markowitz, J. C., & Klerman, G. L. (2007) · Oxford University Press eBooks · doi:10.1093/med:psych/9780195309416.001.0001 · Cited by 239 · see citing works
Fonagy, P., Rost, F., Carlyle, J., McPherson, S., Thomas, R., Pasco Fearon, R. M., Goldberg, D., & Taylor, D. (2015) · World Psychiatry · doi:10.1002/wps.20267 · Cited by 237 · see citing works
Tor, P.-C., Bautovich, A., Wang, M.-J., Martin, D., Harvey, S. B., & Loo, C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09145 · Cited by 230 · see citing works
Kennedy, S. H., Milev, R. V., Giacobbe, P., Ramasubbu, R., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.039 · Cited by 225 · see citing works
Self-citationGoldstrom, I. D., Campbell, J., Rogers, J. A., Lambert, D. B., Blacklow, B., Henderson, M. J., & Manderscheid, R. W. (2005) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-005-0019-x · Cited by 225 · see citing works
Bondolfi, G., Jermann, F., der Linden, M. V., Gex-Fabry, M., Bizzini, L., Rouget, B. W., Myers-Arrazola, L., Gonzalez, C., Segal, Z., Aubry, J.-M., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.007 · Cited by 223 · see citing works
The Dodo Bird Verdict Is Alive and Well--Mostly
Luborsky, L. (2002) · Clinical Psychology Science and Practice · doi:10.1093/clipsy/9.1.2 · Cited by 222 · see citing works
Meron, D., Hedger, N., Garner, M., & Baldwin, D. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.012 · Cited by 220 · see citing works
Antidepressant Pharmacotherapy Failure and Response to Subsequent Electroconvulsive Therapy
Heijnen, W. T. C. J., Birkenhäger, T. K., Wierdsma, A. I., & van den Broek, W. W. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ee0f5f · Cited by 220 · see citing works
Perinatal Antidepressant Use: Understanding Women’s Preferences and Concerns
BATTLE, C. L., SALISBURY, A. L., SCHOFIELD, C. A., & ORTIZ-HERNANDEZ, S. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000438183.74359.46 · Cited by 216 · see citing works
Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes
Morishita, T., Fayad, S. M., Higuchi, M.-A., Nestor, K. A., & Foote, K. D. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0282-1 · Cited by 216 · see citing works
The Effect of Electroconvulsive Therapy on Autobiographical Memory
Fraser, L., O’Carroll, R. E., & Ebmeier, K. P. (2008) · Journal of Ect · doi:10.1097/yct.0b013e3181616c26 · Cited by 216 · see citing works
Brunoni, A. R., Boggio, P. S., Raedt, R. D., Benseñor, I. M., Lotufo, P. A., Namur, V., Valiengo, L. D. C. L., & Vanderhasselt, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.026 · Cited by 215 · see citing works
Kocsis, J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.144 · Cited by 214 · cited 4× · see citing works
“Since the first CBASP trial published in 2000,(114) 5 CBASP studies have been published that provide only mixed results supporting CBASP.(75,115-118) Overall, Level 2 Evidence supports CBASP as a second-line monotherapy, or in combination with antidepressants, for partial-responding or nonresponding patients, in the t…”
BackgroundResultInfluentialProcessing the therapeutic relationship
Hill, C. E., & Knox, S. (2009) · Psychotherapy Research · doi:10.1080/10503300802621206 · Cited by 211 · see citing works
Fuhr, D. C., Salisbury, T. T., De Silva, M. J., Atif, N., van Ginneken, N., Rahman, A., & Patel, V. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0857-5 · Cited by 209 · see citing works
[Solitary median maxillary central incisor syndrome:a case of report].
Kang, L.-Y., & Liu, X. (2014) · PubMed · Cited by 208 · see citing works
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206 · see citing works
Vagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205 · see citing works
Berlim, M. T., den Eynde, F. V., & Daskalakis, Z. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.025 · Cited by 202 · see citing works
Ren, J., Li, H., Palaniyappan, L., Liu, H., Wang, J., Li, C., & Rossini, P. M. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.004 · Cited by 199 · see citing works
Kayser, S., Bewernick, B. H., Grubert, C., Hadrysiewicz, B. L., Axmacher, N., & Schlaepfer, T. E. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.008 · Cited by 194 · see citing works
Psychotherapy for subclinical depression: meta-analysis
Cuijpers, P., Koole, S. L., van Dijke, A., Roca, M., Li, J., & Reynolds, C. F. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.138784 · Cited by 193 · see citing works
George, M. S., Raman, R., Benedek, D. M., Pelic, C. G., Grammer, G. G., Stokes, K. T., Schmidt, M., Spiegel, C., DeAlmeida, N., Beaver, K. L., et al. (2014) · Brain Stimulation · doi:10.1016/j.brs.2014.03.006 · Cited by 193 · see citing works
Therapist effectiveness: Implications for accountability and patient care
Kraus, D. R., Castonguay, L. G., Boswell, J. F., Nordberg, S. S., & Hayes, J. A. (2011) · Psychotherapy Research · doi:10.1080/10503307.2011.563249 · Cited by 192 · see citing works
de Maat, S. M., Dekker, J., Schoevers, R. A., & de Jonghe, F. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2006.10.008 · Cited by 192 · see citing works
A brief behavioral activation treatment for depression
Lejuez, C. W., Hopko, D. R., LePage, J. P., Hopko, S. D., & McNeil, D. W. (2001) · Cognitive and Behavioral Practice · doi:10.1016/s1077-7229(01)80022-5 · Cited by 191 · see citing works
Weitz, E. S., Hollon, S. D., Twisk, J., van Straten, A., Huibers, M. J. H., David, D., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., Cristea, I. A., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1516 · Cited by 187 · see citing works
Self-citationConnolly, K. R., Helmer, A., Cristancho, M. A., Cristancho, P., & O’Reardon, J. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07413 · Cited by 185 · see citing works
Parikh, S. V., Segal, Z. V., Grigoriadis, S., Ravindran, A. V., Kennedy, S. H., Lam, R. W., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.042 · Cited by 183 · cited 1× · see citing works
“Bibliotherapy, the reading and use of self-help materials such as books to treat depression, has been tested in many older trials, particularly as RCTs involving a waitlist control compared to use of the book Feeling Good by David Burns.(141) With the expansion of computer/Internet approaches to self-help, very few bi…”
MethodSelf-citationHuang, H., Coleman, S., Bridge, J. A., Yonkers, K., & Katon, W. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.08.002 · Cited by 180 · see citing works
Luty, S. E., Carter, J. D., McKenzie, J. M., Rae, A. M., FRAMPTON, C. M. A., Mulder, R., & Joyce, P. R. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024729 · Cited by 180 · see citing works
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178 · see citing works
Carlbring, P., Hägglund, M., Luthström, A., Dahlin, M., Kadowaki, Å., Vernmark, K., & Andersson, G. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.020 · Cited by 177 · see citing works
Biesheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J., & Smit, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.016 · Cited by 175 · see citing works
Janicak, P. G., Nahas, Z. H., Lisanby, S. H., Solvason, H. B., Sampson, S. M., McDonald, W. M., Marangell, L. B., Rosenquist, P. B., McCall, W. V., Kimball, J. N., et al. (2010) · Brain stimulation · doi:10.1016/j.brs.2010.07.003 · Cited by 170 · see citing works
Aaronson, S. T., Carpenter, L. L., Conway, C. R., Reimherr, F. W., Lisanby, S. H., Schwartz, T. L., Moreno, F., Dünner, D. L., Lesem, M. D., Thompson, P. M., et al. (2012) · Brain stimulation · doi:10.1016/j.brs.2012.09.013 · Cited by 163 · see citing works
Stubbings, D. R., Rees, C. S., Roberts, L. D., & Kane, R. T. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2564 · Cited by 162 · see citing works
Antenatal and postnatal mental health: summary of updated NICE guidance
Howard, L. M., Megnin-Viggars, O., Symington, I., Pilling, S., & On behalf of the Guideline Development Group (2014) · BMJ · doi:10.1136/bmj.g7394 · Cited by 162 · see citing works
Berlim, M. T., den Eynde, F. V., & Daskalakis, Z. J. (2012) · Psychological Medicine · doi:10.1017/s0033291712002802 · Cited by 160 · see citing works
Internet-delivered psychotherapy for depression in adults
Titov, N. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833ed18f · Cited by 158 · see citing works
Cuijpers, P., Weitz, E., Twisk, J., Kuehner, C., Cristea, I., David, D., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., Faramarzi, M., et al. (2014) · Depression and Anxiety · doi:10.1002/da.22328 · Cited by 158 · see citing works
Self-citationBarber, J. P., Barrett, M. S., Gallop, R., Rynn, M. A., & Rickels, K. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06831 · Cited by 157 · see citing works
Choi, N. G., Marti, C. N., Bruce, M. L., Hegel, M. T., Wilson, N. L., & Kunik, M. E. (2014) · Depression and Anxiety · doi:10.1002/da.22242 · Cited by 156 · see citing works
Donker, T., Bennett, K., Bennett, A., Mackinnon, A., van Straten, A., Cuijpers, P., Christensen, H., & Griffiths, K. M. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2307 · Cited by 154 · see citing works
Olin, B., Berry, Broglio, Bunker, Jayewardene, & Rush (2013) · Medical Devices: Evidence and Research · doi:10.2147/mder.s41017 · Cited by 152 · see citing works
Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the Literature
Petrides, G., Tobias, K. G., Kellner, C. H., & Rudorfer, M. V. (2011) · Neuropsychobiology · doi:10.1159/000328943 · Cited by 151 · see citing works
Schatzberg, A. F., Rush, A. J., Arnow, B. A., Banks, P. L. C., Blalock, J. A., Borian, F. E., Howland, R., Klein, D. N., Kocsis, J. H., Kornstein, S. G., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.5.513 · Cited by 147 · see citing works
Dünner, D. L., Aaronson, S. T., Sackeïm, H. A., Janicak, P. G., Carpenter, L. L., Boyadjis, T. A., Brock, D. G., Bonneh‐Barkay, D., Cook, I. A., Lanocha, K. I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08977 · Cited by 143 · see citing works
Wiles, N. J., Thomas, L., Turner, N., Garfield, K., Kounali, D., Campbell, J., Kessler, D., Kuyken, W., Lewis, G., Morrison, J., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00495-2 · Cited by 139 · see citing works
Simon, W., Lambert, M. J., Harris, M. W., Busath, G., & Vazquez, A. (2012) · Psychotherapy Research · doi:10.1080/10503307.2012.698918 · Cited by 137 · see citing works
Berlim, M. T., McGirr, A., den Eynde, F. V., Fleck, M. P., & Giacobbe, P. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.016 · Cited by 136 · see citing works
Kirkham, J. G., Choi, N., & Seitz, D. P. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4358 · Cited by 136 · see citing works
Manicavasgar, V., Parker, G., & Perich, T. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.027 · Cited by 136 · see citing works
Brief Psychotherapy for Depression: A Systematic Review and Meta-Analysis
Nieuwsma, J. A., Trivedi, R. B., McDuffie, J., Kronish, I., Benjamin, D., & Williams, J. W. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.43.2.c · Cited by 135 · see citing works
Verwijk, E., Comijs, H. C., Kok, R., Spaans, H., Stek, M. L., & Scherder, E. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.024 · Cited by 135 · see citing works
Bond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400104 · Cited by 133 · see citing works
Self-citationGroup psychological therapies for depression in the community: systematic review and meta-analysis
Huntley, A. L., Araya, R., & Salisbury, C. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092049 · Cited by 132 · see citing works
Farahani, A., & Correll, C. U. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07324 · Cited by 131 · see citing works
Schramm, E., Zobel, I., Dykierek, P., Kech, S., Brakemeier, E.-L., Külz, A., & Berger, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.003 · Cited by 127 · see citing works
Dickens, C., Cherrington, A., Adeyemi, I., Roughley, K., Bower, P., Garrett, C., Bundy, C., & Coventry, P. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ac009 · Cited by 127 · see citing works
Brakemeier, E., Merkl, A., Wilbertz, G., Quante, A., Regen, F., Bührsch, N., van Hall, F., Kischkel, E., Danker‐Hopfe, H., Anghelescu, I. G., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.030 · Cited by 121 · see citing works
Kriston, L., von Wolff, A., Westphal, A., Hölzel, L. P., & Härter, M. (2014) · Depression and Anxiety · doi:10.1002/da.22236 · Cited by 119 · see citing works
Guidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine · doi:10.1017/s0033291710000826 · Cited by 118 · see citing works
McGirr, A., Van den Eynde, F., Tovar-Perdomo, S., Fleck, M. P. A., & Berlim, M. T. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.068 · Cited by 117 · see citing works
Dunne, R. A., & McLoughlin, D. M. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.615863 · Cited by 117 · see citing works
Web-Based Intervention Programs for Depression: A Scoping Review and Evaluation
Renton, T., Tang, H., Ennis, N., Cusimano, M. D., Bhalerao, S., Schweizer, T. A., & Topolovec-Vranic, J. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3147 · Cited by 116 · see citing works
de Maat, S. C. M., Dekker, J., Schoevers, R. A., & de Jonghe, F. E. R. E. R. (2006) · Psychotherapy Research · doi:10.1080/10503300600756402 · Cited by 116 · see citing works
Clarke, K., Mayo-Wilson, E., Kenny, J., & Pilling, S. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.04.002 · Cited by 113 · see citing works
Grubert, C., Hurlemann, R., Bewernick, B. H., Kayser, S., Hadrysiewicz, B., Axmacher, N., Sturm, V., & Schlaepfer, T. E. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.583940 · Cited by 112 · see citing works
McDonald, W. M., Durkalski, V., Ball, E. R., Holtzheimer, P. E., Pavlicová, M., Lisanby, S. H., Avery, D., Anderson, B. S., Nahas, Z. H., Zarkowski, P. A., et al. (2011) · Depression and Anxiety · doi:10.1002/da.20885 · Cited by 110 · see citing works
Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy
Prudic, J., Haskett, R. F., McCall, W. V., Isenberg, K. E., Cooper, T. B., Rosenquist, P. B., Mulsant, B. H., & Sackeïm, H. A. (2013) · Journal of Ect · doi:10.1097/yct.0b013e31826ea8c4 · Cited by 106 · see citing works
Vallury, K. D., Jones, M., & Oosterbroek, C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4145 · Cited by 105 · see citing works
Noda, Y., Silverstein, W. K., Barr, M. S., Vila-Rodriguez, F., Downar, J., Rajji, T., Fitzgerald, P. B., Mulsant, B. H., Vigod, S., Daskalakis, Z., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001609 · Cited by 103 · see citing works
Martin, J. L. R., & Martín-Sánchez, E. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.006 · Cited by 102 · see citing works
Berlim, M. T., den Eynde, F. V., & Daskalakis, Z. J. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07996 · Cited by 102 · see citing works
Sehatzadeh, S., Tu, H., Palimaka, S., Yap, B., O’Reilly, D. J., & Bowen, J. M. (2016) · Cited by 102 · see citing works
Serafini, G., Pompili, M., Belvederi Murri, M., Respino, M., Ghio, L., Girardi, P., Fitzgerald, P. B., & Amore, M. (2015) · Neuropsychobiology · doi:10.1159/000381351 · Cited by 101 · see citing works
Puigdemont, D., Portella, M. J., Pérez-Egea, R., Molet, J., Gironell, A., de Diego-Adeliño, J., Martín, A., Rodríguez, R., Àlvarez, E., Artigas, F., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130295 · Cited by 100 · see citing works
(2012) · PubMed · Cited by 100 · see citing works
Brunoni, A. R., Baeken, C., Machado‐Vieira, R., Gattaz, W. F., & Vanderhasselt, M. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.892633 · Cited by 98 · see citing works
Molenaar, P. J., Boom, Y., Peen, J., Schoevers, R. A., Van, R., & Dekker, J. J. (2011) · British Journal of Clinical Psychology · doi:10.1348/014466510x516975 · Cited by 96 · see citing works
Watts, B. V., Groft, A., Bagian, J. P., & Mills, P. D. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181f6d17f · Cited by 95 · see citing works
Brakemeier, E.-L., Radtke, M., Engel, V., Zimmermann, J., Tuschen-Caffier, B., Hautzinger, M., Schramm, E., Berger, M., & Normann, C. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000369586 · Cited by 94 · see citing works
Kedzior, Azorina, V., & Reitz, S. C. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s58405 · Cited by 94 · see citing works
Kayser, S., Bewernick, B. H., Matusch, A., Hurlemann, R., Soehle, M., & Schlaepfer, T. E. (2015) · Psychological Medicine · doi:10.1017/s0033291714002244 · Cited by 94 · see citing works
Lam, R. W. M., Kennedy, S. H., Parikh, S. V., MacQUEEN, G. M., Milev, R. V., Ravindran, A. V., & the CANMAT Depression Work Group (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659061 · Cited by 94 · see citing works
Self-citationvan Schaik, A. M., Comijs, H. C., Sonnenberg, C., Beekman, A. T. F., Sienaert, P. A., & Stek, M. L. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31820dcbf9 · Cited by 93 · see citing works
Interpersonal psychotherapy for postpartum depression: a systematic review
Miniati, M., Callari, A., Calugi, S., Rucci, P., Savino, M., Mauri, M., & Dell’Osso, L. (2014) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0442-7 · Cited by 91 · see citing works
Chiesa, A., Castagner, V., Andrisano, C., Serretti, A., Mandelli, L., Porcelli, S., & Giommi, F. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.02.003 · Cited by 89 · see citing works
Geschwind, N., Peeters, F., Huibers, M., van Os, J., & Wichers, M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.104851 · Cited by 89 · see citing works
Khatri, N., Marziali, E., Tchernikov, I., & Sheppard, N. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s57832 · Cited by 87 · see citing works
Okumura, Y., & Ichikura, K. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.023 · Cited by 86 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Leszcz M, Pain C, Hunter J, . Psychotherapy essentials to go: achieving psychotherapy effectiveness. New York (NY): Norton; 2015.
- 10.1192/bjp.bp.112.113696 · DOI · Paper page
- Baldwin SA Imel ZE. Therapist effects: findings and methods. In: Lambert MJ editor. Bergin and Garfield’s handbook of psychotherapy and behavior changes. 6th ed. New York (NY): John Wiley; 2013. pp. 258–297.
Cited by
Sorted by citations
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382 · see citing works
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363 · see citing works
Self-citationKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,150 · see citing works
Self-citationPeters, S. K., Dunlop, K., & Downar, J. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00104 · Cited by 611 · see citing works
Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614 · see citing works
Brunoni, A. R., Chaimani, A., Moffa, A. H., Razza, L. B., Gattaz, W. F., Daskalakis, Z. J., & Carvalho, A. F. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3644 · Cited by 520 · see citing works
Treatment resistance in psychiatry: state of the art and new directions
Howes, O. D., Thase, M. E., & Pillinger, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01200-3 · Cited by 413 · see citing works
Bahji, A., Vazquez, G. H., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.071 · Cited by 408 · see citing works
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337 · see citing works
Self-citationPrediction of electroconvulsive therapy response and remission in major depression: meta-analysis
van Diermen, L., van den Ameele, S., Kamperman, A. M., Sabbe, B., Vermeulen, T., Schrijvers, D. L., & Birkenhäger, T. K. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2017.28 · Cited by 334 · see citing works
Cognitive Impairment in Major Depressive Disorder
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852918001207 · Cited by 320 · see citing works
McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278 · see citing works
When to consider electroconvulsive therapy (ECT)
Kellner, C. H., Obbels, J., & Sienaert, P. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13134 · Cited by 239 · see citing works
Noninvasive brain stimulation in psychiatric disorders: a primer
Brunoni, A. R., Sampaio-Júnior, B., Moffa, A. H., Aparicio, L. V. M., Gordon, P. C., Klein, I., Rios, R. M., Razza, L. B., Loo, C. K. A., Padberg, F., et al. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0018 · Cited by 195 · see citing works
Moffa, A. H., Martin, D. M., Alonzo, A., Bennabi, D., Blumberger, D. M., Benseñor, I. M., Daskalakis, Z. J., Fregni, F., Haffen, É., Lisanby, S. H., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109836 · Cited by 178 · see citing works
Liu, Z., Qiao, D., Xu, Y., Zhao, W., Yang, Y., Wen, D., Li, X., Nie, X., Dong, Y., Tang, S., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/26883 · Cited by 169 · see citing works
Should antidepressants be used for major depressive disorder?
Jakobsen, J. C., Gluud, C., & Kirsch, I. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111238 · Cited by 162 · see citing works
Deep brain stimulation targets for treating depression
Drobisz, D., & Damborská, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.004 · Cited by 159 · see citing works
Cassano, P., Petrie, S. R., Mischoulon, D., Cusin, C., Katnani, H. A., Yeung, A., Taboada, L. H. D., Archibald, A., Bui, É., Baer, L., et al. (2018) · Photomedicine and Laser Surgery · doi:10.1089/pho.2018.4490 · Cited by 157 · see citing works
Sajjadian, M., Lam, R. W. M., Milev, R. V., Rotzinger, S., Frey, B. N., Soares, C. N., Parikh, S. V., Foster, J. A., Turecki, G., Müller, D. J., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721003871 · Cited by 159 · see citing works
“…of antidepressants, augmentation pharmacological agents, psychological therapies, and brain stimulation procedures are effective for depression (Cipriani et al., 2018; Kennedy et al., 2016; Milev et al., 2016; Parikh et al., 2016), but the efficacy of these treatments varies across individuals.”
BackgroundSelf-citationAn Overview of Noninvasive Brain Stimulation: Basic Principles and Clinical Applications
Bhattacharya, A., Kambhampati, M., Sreepada, S. S. S., Sathyaprabha, T. N., Pal, P. K., Chen, R. E., & Udupa, K. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.158 · Cited by 160 · see citing works
Ross, E. L., Zivin, K., & Maixner, D. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0768 · Cited by 151 · see citing works
Dionisie, V., Filip, G. A., Manea, M. C., Manea, M., & Riga, S. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00777-5 · Cited by 141 · see citing works
Bottomley, J., LeReun, C., Diamantopoulos, A., Mitchell, S., & Gaynes, B. N. (2019) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152156 · Cited by 142 · see citing works
Vagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138 · see citing works
Risio, L. D., Borgi, M., Pettorruso, M., Miuli, A., Ottomana, A. M., Sociali, A., Martinotti, G., Nicolò, G., Macrı̀, S., Giannantonio, M. D., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01055-2 · Cited by 142 · see citing works
Neuromodulation techniques – From non-invasive brain stimulation to deep brain stimulation
Davidson, B., Bhattacharya, A., Sarica, C., Darmani, G., Raies, N., Chen, R. E., & Lozano, A. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00330 · Cited by 152 · see citing works
Caldieraro, M. A., & Cassano, P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.048 · Cited by 134 · see citing works
Kishi, T., Ikuta, T., Sakuma, K., Okuya, M., Hatano, M., Matsuda, Y., & Iwata, N. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01824-z · Cited by 136 · see citing works
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
Vita, A., Gäebel, W., Mucci, A., Sachs, G., Barlati, S., Giordano, G. M., Nibbio, G., Nordentoft, M., Wykes, T., & Galderisi, S. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.2315 · Cited by 134 · see citing works
“ECT, however, is frequently associated with cognitive adverse effects, including transient cognitive impairment and memory deficits [149, 150].”
Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT
Thase, M. E., Wright, J. H., Eells, T. D., Barrett, M. S., Wisniewski, S. R., Balasubramani, G. K., McCrone, P., & Brown, G. K. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17010089 · Cited by 131 · see citing works
Complementary therapies for clinical depression: an overview of systematic reviews
Haller, H., Anheyer, D., Cramer, H., & Dobos, G. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028527 · Cited by 128 · see citing works
Schulze, L., Feffer, K., Lozano, C. S., Giacobbe, P., Daskalakis, Z. J., Blumberger, D. M., & Downar, J. H. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.11.002 · Cited by 122 · see citing works
Repetitive transcranial magnetic stimulation treatment for depressive disorders
Baeken, C., Brem, A., Arns, M., Brunoni, A. R., Filipčić, I., Ganho-Ávila, A., Langguth, B., Padberg, F., Poulet, E., Rachid, F., et al. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000533 · Cited by 120 · see citing works
The neuroscience of sadness: A multidisciplinary synthesis and collaborative review
Arias-López, J. A., Williams, C., Raghvani, R., Aghajani, M., Báez, S., Belzung, C., Booij, L., Busatto, G. F., Chiarella, J., Fu, C. H. Y., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.006 · Cited by 132 · see citing works
Electroconvulsive therapy: 80 years old and still going strong
Gazdag, G., & Ungvari, G. S. (2018) · World Journal of Psychiatry · doi:10.5498/wjp.v9.i1.1 · Cited by 113 · see citing works
Kessler, R. C. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000377 · Cited by 103 · see citing works
Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., Kato, Y., Gill, S., Clarke, P., Ng, F., et al. (2021) · Brain Stimulation · doi:10.1016/j.brs.2021.07.018 · Cited by 105 · see citing works
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
Ramaholimihaso, T., Bouazzaoui, F., & Kaladjian, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.572533 · Cited by 114 · see citing works
Vida, R. G., Sághy, E., Bella, R., Kovács, S., Erdősi, D., Józwiak‐Hagymásy, J., Zemplenyi, A. T., Tényi, T., Osváth, P., & Vörös, V. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05033-y · Cited by 117 · see citing works
Zhang, W., Deng, B., Xie, F., Zhou, H., Guo, J., Jiang, H., Sim, A., Tang, B., & Wang, Q. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101589 · Cited by 112 · see citing works
The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services
Tickell, A., Ball, S., Bernard, P., Kuyken, W., Marx, R., Pack, S., Strauss, C., Sweeney, T., & Crane, C. (2020) · Mindfulness · doi:10.1007/s12671-018-1087-9 · Cited by 99 · see citing works
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104 · see citing works
Self-citationBennabi, D., Charpeaud, T., Yrondi, A., Genty, J., Destouches, S., Lancrenon, S., Allaïli, N., Bellivier, F., Bougerol, T., Camus, V., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2237-x · Cited by 101 · see citing works
Tavares, D. F., Myczkowski, M. L., Alberto, R. L., Valiengo, L. D. C. L., Rios, R. M., Gordon, P. C., Sampaio-Júnior, B., Klein, I., Mansur, C. G., Marcolin, M. A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.26 · Cited by 98 · see citing works
US Food and Drug Administration approval of esketamine and brexanolone
Cristea, I. A., & Naudet, F. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30292-5 · Cited by 98 · see citing works
Rybak, Y. E., Lai, K. S. P., Ramasubbu, R., Vila‐Rodriguez, F., Blumberger, D. M., Chan, P., Delva, N. J., Giacobbe, P., Gosselin, C., Kennedy, S. H., et al. (2021) · Depression and Anxiety · doi:10.1002/da.23135 · Cited by 101 · see citing works
Self-citationVázquez, G. H., Bahji, A., Undurraga, J., Tondo, L., & Baldessarini, R. J. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211013579 · Cited by 95 · see citing works
Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives
Lloyd, J. R., Silverman, E. R., Kugler, J., & Cooper, J. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s231573 · Cited by 99 · see citing works
Complementary Therapies for Mental Health Disorders
Asher, G. N., Gerkin, J., & Gaynes, B. N. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.04.004 · Cited by 93 · see citing works
Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders
Bremner, J. D., Gurel, N. Z., Wittbrodt, M. T., Shandhi, M. M. H., Rapaport, M. H., Nye, J. A., Pearce, B. D., Vaccarino, V., Shah, A. J., Park, J., et al. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030119 · Cited by 93 · see citing works
Wu, C., Liu, P., Fu, H., Chen, W., Cui, S., Lu, L., & Tang, C. (2018) · Medicine · doi:10.1097/md.0000000000013845 · Cited by 91 · see citing works
Dodd, S., Bauer, M., Carvalho, A. F., Eyre, H. A., D, M. F. M., Kasper, S. F., Kennedy, S. H., Khoo, J., López‐Jaramillo, C., Malhi, G. S., et al. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1851052 · Cited by 95 · see citing works
“…(Kennedy et al. 2009; Lam, Kennedy, et al. 2009; Kennedy et al. 2016; Lam, Kennedy, et al. 2016; Lam, McIntosh, et al. 2016; MacQueen et al. 2016; Milev et al. 2016; Parikh et al. 2016; Ravindran et al. 2016), RANZCP (Ellis 2004; Malhi et al. 2015) and NICE guidelines (NICE Guidance 2018).”
BackgroundSelf-citationde Abreu Costa, M., D’Alò de Oliveira, G. S., Tatton-Ramos, T., Manfro, G. G., & Salum, G. A. (2019) · Mindfulness · doi:10.1007/s12671-018-1058-1 · Cited by 85 · see citing works
A Framework for the Empirical Investigation of Mindfulness Meditative Development
Galante, J., Grabovac, A. D., Wright, M., Ingram, D. M., Dam, N. T. V., Sanguinetti, J. L., Sparby, T., van Lutterveld, R., & Sacchet, M. D. (2023) · Mindfulness · doi:10.1007/s12671-023-02113-8 · Cited by 87 · see citing works
“The MBCT programme is officially recommended by British and Canadian treat-ment guidelines as first-line treatment for the prevention of depressive relapse (National Institute for Health and Care Excellence, 2009; Parikh et al., 2016).”
A systematic review and meta-analysis on the efficacy of Internet-delivered behavioral activation
Huguet, A., Miller, A., Kisely, S. R., Rao, S., Saadat, N., & McGrath, P. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.073 · Cited by 85 · see citing works
Fornaro, M., Carvalho, A. F., Fusco, A., Anastasia, A., Solmi, M., Berk, M., Sim, K., Vieta, E., & de Bartolomeis, A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.109 · Cited by 80 · see citing works
Miron, J., Jodoin, V. D., Lespérance, P., & Blumberger, D. M. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211042696 · Cited by 85 · see citing works
Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76 · see citing works
Liu, C., Chen, H., Zhou, F., Long, Q., Wu, K., Lo, L., Hung, T., Liu, C.-Y., & Chiou, W. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01996-4 · Cited by 79 · see citing works
Improving Depression Outcome by Patient-Centered Medical Management
Rush, A. J., & Thase, M. E. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040398 · Cited by 76 · see citing works
Kaster, T. S., Vigod, S. N., Gomes, T., Sutradhar, R., Wijeysundera, D. N., & Blumberger, D. M. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00168-1 · Cited by 77 · see citing works
Loh, E., Mirkowski, M., Agudelo, A. R., Allison, D. J., Benton, B., Bryce, T. N., Guilcher, S. J. T., Jeji, T., Kras‐Dupuis, A., Kreutzwiser, D., et al. (2022) · Spinal Cord · doi:10.1038/s41393-021-00744-z · Cited by 86 · see citing works
McGirr, A., Vila-Rodriguez, F., Cole, J., Torres, I. J., Arumugham, S. S., Keramatian, K., Saraf, G., Lam, R. W., Chakrabarty, T., & Yatham, L. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0963 · Cited by 76 · see citing works
Self-citationFilipčić, I., Filipčić, I. Š., Milovac, Ž., Sučić, S., Gajšak, T., Ivezić, E., Bašić, S., Bajić, Ž., & Heilig, M. A. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.020 · Cited by 76 · see citing works
Ge, R., Blumberger, D. M., Downar, J. H., Daskalakis, Z. J., Dipinto, A. A., Tham, J. C. W., Lam, R. W. M., & Vila‐Rodriguez, F. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.060 · Cited by 72 · see citing works
Self-citationTheta burst stimulation for depression: a systematic review and network and pairwise meta-analysis
Kishi, T., Ikuta, T., Sakuma, K., Hatano, M., Matsuda, Y., Wilkening, J., Goya-Maldonado, R., Tik, M., Williams, N. R., Kito, S., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02630-5 · Cited by 74 · see citing works
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
Wu, C.-Y., Yang, L.-M., Feng, S., Zhu, L., Yang, L.-D., Liu, T.-O. C., & Duan, R. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00216-8 · Cited by 65 · see citing works
(2019) · Europe PMC (PubMed Central) · Cited by 72 · see citing works
Trevizol, A. P., Downar, J., Vila-Rodriguez, F., Thorpe, K. E., Daskalakis, Z. J., & Blumberger, D. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100349 · Cited by 70 · see citing works
Feffer, K., Lee, H. H., Mansouri, F., Giacobbe, P., Vila‐Rodriguez, F., Kennedy, S. H., Daskalakis, Z. J., Blumberger, D. M., & Downar, J. H. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.10.010 · Cited by 70 · see citing works
Self-citationDunlop, B. W., LoParo, D., Kinkead, B. L., Mletzko, T., Cole, S. P., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18091075 · Cited by 65 · see citing works
Lee, J. S., Gierc, M. S. H., Vila‐Rodriguez, F., Puterman, E. M., & Faulkner, G. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.043 · Cited by 73 · see citing works
Thase, M. E., McCrone, P., Barrett, M. S., Eells, T. D., Wisniewski, S. R., Balasubramani, G. K., Brown, G. K., & Wright, J. H. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000508143 · Cited by 60 · see citing works
Ravindran, A., Balneaves, L., Faulkner, G., Ortiz, A., Mcintosh, D., Morehouse, R., Ravindran, L. N., Yatham, L., Kennedy, S., Lam, R. W., et al. (2018) · Focus · doi:10.1176/appi.focus.16106 · Cited by 348 · see citing works
Self-citationRecent Advances in Non-invasive Brain Stimulation for Major Depressive Disorder
Liu, S., Sheng, J., Li, B., & Zhang, X. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00526 · Cited by 63 · see citing works
Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01770-w · Cited by 66 · see citing works
Shulman, B., Dueck, R., Ryan, D. M., Breau, G., Sadowski, I., & Misri, S. K. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.065 · Cited by 63 · see citing works
Weightman, M. (2020) · Journal of International Medical Research · doi:10.1177/0300060520928686 · Cited by 62 · see citing works
Nogovitsyn, N., Muller, M., de Souza, R. M., Hassel, S., Arnott, S. R., Davis, A. D., Hall, G. B., Harris, J. K., Zamyadi, M., Metzak, P. D., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0542-1 · Cited by 62 · see citing works
Self-citationRosenblat, J. D., Husain, M. I., Lee, Y. L., McIntyre, R. S., Mansur, R. B., Castle, D. J., Offman, H., Parikh, S. V., Frey, B. N., Schaffer, A., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221111371 · Cited by 68 · see citing works
Self-citationVigo, D., Haro, J. M., Hwang, I. H., Aguilar‐Gaxiola, S., Alonso, J., Borges, G. L. G., Bruffaerts, R., Caldas‐de‐Almeida, J. M., de Girolamo, G., Florescu, S., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720003797 · Cited by 61 · see citing works
“Cost-effective interventions to treat mental disorders have been tested in countries across income levels and are ready for global scaleup (Patel et al., 2016; Patel et al., 2018; Vigo, et al., 2019).”
Jodoin, V. D., Miron, J., & Lespérance, P. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.10.019 · Cited by 61 · see citing works
McIntyre, R. S., Millson, B., & Power, G. S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.045 · Cited by 60 · see citing works
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Baptista, A. F., Baltar, A., Okano, A. H., Moreira, A., Campos, A. C. P., Fernandes, A. M., Brunoni, A. R., Badran, B. W., Tanaka, C., de Andrade, D. C., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573718 · Cited by 59 · see citing works
Song, J., Liu, Z., Huang, J., Wu, J., & Tao, J. (2021) · Medicine · doi:10.1097/md.0000000000023819 · Cited by 58 · see citing works
Chen, J.-J., Zeng, B., Wu, C., Stubbs, B., Carvalho, A. F., Brunoni, A. R., Su, K., Tu, Y., Wu, Y., Chen, T., et al. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.1497 · Cited by 61 · see citing works
Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression
MacMaster, F. P., Croarkin, P. E., Wilkes, T. C., McLellan, Q., Langevin, L. M., Jaworska, N., Swansburg, R. M., Jasaui, Y., Zewdie, E., Ciechanski, P., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00170 · Cited by 56 · see citing works
Hong, R. H., Murphy, J., Michalak, E. E., Chakrabarty, T., Wang, Z., Parikh, S. V., Culpepper, L., Yatham, L. N., Lam, R. W. M., & Chen, J. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s283731 · Cited by 58 · see citing works
Self-citationHamel, C., Lang, E., Morissette, K., Beck, A., Stevens, A., Skidmore, B., Colquhoun, H., LeBlanc, J., Moore, A., Riva, J. J., et al. (2019) · Systematic Reviews · doi:10.1186/s13643-018-0930-3 · Cited by 55 · see citing works
Self-citationChen, L., Klooster, D., Tik, M., Thomas, E. H. X., Downar, J. H., Fitzgerald, P. B., Williams, N., & Baeken, C. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000364 · Cited by 58 · see citing works
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 61 · see citing works
Smith, J., Disalvo, M., Green, A., Ceranoglu, T. A., Anteraper, S., Croarkin, P., & Joshi, G. (2022) · Neuropsychology Review · doi:10.1007/s11065-022-09564-1 · Cited by 47 · see citing works
Kanner, A. M., Scharfman, H. E., Jetté, N., Anagnostou, E. A., Bernard, C., Camfield, C., CAMFIELD, P. R., Legg, K. T., Dinstein, I., Giacobbe, P., et al. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.09.014 · Cited by 55 · see citing works
Mendlowitz, A. B., Shanbour, A., Downar, J. H., Vila‐Rodriguez, F., Daskalakis, Z. J., Isaranuwatchai, W., & Blumberger, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222546 · Cited by 52 · see citing works
Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy for Depressive Disorders
Lee, S., & Cho, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_16 · Cited by 56 · see citing works
Autonomic balance determines the severity of COVID-19 courses
Leitzke, M., Stefanovic, D., Meyer, J.-J., Schimpf, S., & Schönknecht, P. (2020) · Bioelectronic Medicine · doi:10.1186/s42234-020-00058-0 · Cited by 49 · see citing works
Vergallito, A., Gallucci, A., Pisoni, A., Punzi, M., Caselli, G., Ruggiero, G. M., Sassaroli, S., & Lauro, L. J. R. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.210050 · Cited by 53 · see citing works
Ross, E. L., Vijan, S. S., Miller, E. M., Valenstein, M. M., & Zivin, K. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1480 · Cited by 50 · see citing works
Bulubas, L., Padberg, F., Bueno, P. V. S., Duran, F., Busatto, G. F., Amaro, E., Benseñor, I. M., Lotufo, P. A., Goerigk, S. A., Gattaz, W. F., et al. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.05.006 · Cited by 48 · see citing works
- Authors
- Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V., Ravindran, A. V., Uher, R., & the CANMAT Depression Work Group
- Affiliations
- University of Toronto (CA)
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia
- CBT Associates, Toronto, Ontario
- University of British Columbia (CA)
- University of Calgary (CA)
- Queen's University (CA)
- Dalhousie University (CA)
- ORCID
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-08-11
- Volume
- 61
- Issue
- 9
- Pages
- 524-539
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC4994791
- OpenAlex
- W2485472464
- Cited by
- 562
- References
- 264
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 54 · 2023: 45 · 2022: 77 · 2021: 82 · 2020: 101 · 2019: 73 · 2018: 49 · 2017: 39 · 2016: 9
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sunovion
- Valeant Pharmaceuticals International
- Canadian Network for Mood and Anxiety Treatments
- Queen's University
- Grand Challenges Canada
- Ministero dello Sviluppo Economico
- Vancouver Coastal Health Research Institute
- H. Lundbeck A/S
- St. Jude Medical
- Allergan
- University Health Network Foundation
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- major depressive disorder, neurostimulation, transcranial direct current stimulation, repetitive transcranial magnetic stimulation, electroconvulsive therapy, magnetic seizure therapy, vagus nerve stimulation, deep brain stimulation, treatment-resistant depression, antidepressant-refractory depression, CANMAT guidelines
- MeSH terms
- Canada, Major Depressive Disorder, Humans, Psychotherapy, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review